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1 INTRODUCTION   
 
1.1 Relevance of the Research Topic  
Modern economies are characterized by continuous and rapid innovation fuelled by 
technological and scientific advances. For firms competing in this environment, 
continuous access to new information, know-how, and ideas1 is essential to innovate, 
which in turn, is necessary to achieve competitive advantage and organizational survival 
(Bierly and Chakrabarti, 1996; Davila, 2007). However, given the pace with which 
knowledge develops around the world and along numerous scientific and technological 
frontiers, no firm can internally develop all the expertise and capabilities needed to 
compete (Grindley and Teece, 1997). Firms must, therefore, continuously monitor and 
absorb knowledge from other organizations, including domestic and international firms, 
government laboratories, and universities (Arora and Gambardella, 1990; Powell et al.,  
1996; Liebeskind et al.,  1996). One way in which a firm can access external knowledge 
is by engaging in inter-organizational alliances (Inkpen, 1998). Empirical research has 
confirmed that strategic alliances are an important source of scientific and technological 
knowledge which is a key input factor for innovation (Mowery et al., 1996; Ahuja, 
2000) and firm performance (Stuart, 2000). This dissertation follows this logic and 
combines research on innovation and inter-organizational collaboration but broadens it 
to the level of individual collaborations.  
 
                                                 
1 In the realm of this dissertation, “knowledge” is used as an umbrella term to cover data, information, 
ideas, know-how and expertise. Even though these concepts have significantly different meanings and 
properties (Boisot and Canals, 2004), their differences are hardly relevant for this dissertation. 
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1.1.1 Innovation  
Innovation is a central human activity and is as old as mankind itself. It is an inherent 
characteristic of humans to think about new and better ways of doing something. The 
world we know today would not be possible without it. From the most simple human 
achievements and ideas (e.g., the wheel, the alphabet or printing) to the most 
sophisticated accomplishments (e.g., advanced medical treatment s, Apollo 11 and 
modern information technology), nothing would exist without humanity’s innovative 
drive (Fagerberg, 2005).  
 
Despite its utmost importance, innovation has only been examined at the periphery of 
scholarly activities in the history of management and economic theory. With the notable 
exception of Schumpter (1939), Economics has long focused on other topics (e.g., 
optimal factor allocation and how markets work) while neglecting innovation-related 
issues (Fagerberg and Verspagen, 2009). However, this is changing, and research on 
innovation has flourished during the last few decades. More recent research has fostered 
our understanding of innovation, its general role in society and its economic 
consequences. Today, there is general consensus that:  
 
• Innovation infuses novelty (and variety) in the economic and social arena and it 
is the main driver of economic progress.  
• And, innovation is a powerful factor, explaining performance differences 
between firms, regions and countries. Innovative firms, regions and countries 
outperform less innovative firms, regions and countries and have higher 
productive volumes and income than less innovative ones. 
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Most of past research has focused (on the mostly positive) effects of innovation, while 
the actual processes underlying innovative activities have often been treated as a “black 
box” (particularly in Economics). This focus has begun to shift only gradually to 
encompass the various factors influencing and strengthening innovation, and researchers 
are now using a variety of different theoretical lenses to open the innovation “black 
box” and obtain a more fine-tuned picture of innovation activities (Rosenberg, 1994).  
 
One widely accepted factor within more recent studies is that innovation, by its very 
fundamental nature, is the combination or recombination of existing ideas, skills, 
capabilities, resources or knowledge (Galunic and Rodan, 1998; Fleming, 2001; 
Henderson and Clark, 1990).1 This means that the bigger the variety of input factors 
within a system, the greater the possible scope of combinations and the greater the 
resulting complexity of innovations. Thereby, it is generally assumed that this trend is 
progressive and that complexity increases (Fagerberg, 2005). The growing complexity 
of innovation implies that even large organizations are increasingly dependent on 
external inputs. Modern drug development illustrates this nicely. The pharmaceutical 
industry has always been characterized by its continuous scientific and technological 
change. However, the so-called molecular, biotech revolution (Malerba and Orsenigo, 
2002) has increased this complexity even further in an already highly sophisticated 
industry. Compared to traditional pharmaceutical firms that have developed their 
competitive advantage through capabilities linked to medicinal chemistry, 
biotechnology firms are usually experts in the rapidly evolving field of molecular 
biology. Molecular biology has opened an array of new frontiers for research (including 
                                                 
1
 This idea can be traced back to Schumpeter’s early work. 
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genomics, proteomics, genetic engineering, and gene therapy) and has also spawned 
hundreds of technologies (related to target identification, clinical trials, screening, and 
bioinformatics) that can be applied to research processes (Pisano, 2002). Thus, there is 
an ever- increasing number of ‘locks and keys’, particularly in pharmaceutical research 
and drug development, and no firm can master them all. In this environment, sources of 
new scientific and technological knowledge can come from an array of fields and a 
number of specialized firms, academic laboratories, and government institutions. In 
order to succeed in this industry, firms must reach across their organizational 
boundaries to sources of new knowledge and capabilities on both the scientific and 
technological fronts (Arora and Gambardella, 1990; Powell et al.  1996; Liebeskind et 
al.  1996). 
 
This increasing complexity and need for boundary spanning activities leads directly to 
the second generally accepted finding regarding innovation research, namely, that 
innovation is hardly the activity of a single individual actor (Davila, 2007). Instead, 
innovation activities are embedded and interdependent in a wide network of 
relationships with various interconnected actors (Edquist, 2005). Several authors 
analyse innovation on the basis of sector and technological systems (Malerba, 2004; 
Malerba, 2002; Geels, 2004), while others focus  on regional and national systems of 
innovation (Castellacci, 2009; Lundvall et al.,  2002). Common to all these studies is 
their determination that innovation activities are embedded in a network of multiple 
actors crossing various organizational and institutional boundaries.  
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Both the increasing complexity within innovation and its systemic nature point directly 
to the increasing importance of inter-organizational relationships, the second key 
research tradition on which this dissertation is grounded.  
 
1.1.2 Alliances1 
During the last few decades alliances and organizational collaboration have become key 
issues for managers and researchers alike. Today, they are ubiquitous phenomena, 
crossing sectors, industries and countries (Gulati, 1998; Inkpen, 2002). The motives 
behind alliances encompass a wide range of reasons, including risk reduction, 
economies of scale and scope, access to complementary technology and resources, 
overcoming governmental barriers, international expansion, the search for legitimacy 
and blocking competition (Contractor and Lorange, 2004). Particularly, learning and 
knowledge-related advantages linked to innovation have been at the centre of recent 
alliance research (Inkpen, 2002).  
 
However, alliances not only provide benefits for organizations. They come with a set of 
new problems  and challenges, e.g., learning races (Hamel, 1991; Khanna et al.  1998), 
partner selection (Beckman et al.  2004; Mowery et al.  1998), and contract specification 
(Reuer and Arino, 2007). Additionally, alliances are organizational mechanisms that 
                                                 
1
 The terms “alliance” and “inter-organizational collaboration” are often used interchangeably to 
encompass a broad range of business activities. These activities can range from very short arms -length 
contracts to equity joint ventures, from informal agreements between firms in the same local cluster to 
highly structured contracts between international firms, and from small co-branding projects to the joint 
development of highly sophisticated and large-scale projects such as airplanes (Contractor and Lorange, 
2004). Within this study, alliances are understood as a means for organizational collaboration between a 
firm and a second organization (another company, university, research institute, etc.) in order to access 
and develop knowledge and develop patents in the process of drug development The characterization as 
an organizational-level relationship is particularly relevant because the central theme of this dissertation is 
the contrast between “classical” organizational-level collaborations (“alliances”) and individual-level 
collaborations. 
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take time to establish and, as they’re costly in terms of managerial time and attention, 
they must be limited in number and targeted for specific needs. In an environment 
where the nature, location, and type of potential knowledge sources are continuously 
changing, firms may need to develop more flexible mechanisms for knowledge 
acquisition. In biotechnology, for instance, given the uncertainty associated to the 
scientific developmental process and the applicability and usefulness of knowledge 
absorbed from any particular target (whether a university or a firm), it is important that 
companies have some flexibility in setting up (and potentially dissolving) the inter-
organizational mechanisms that will facilitate knowledge absorption. 
 
1.2 Research Question 
Despite the vast amount of research on collaborative arrangements for innovation, only 
a few studies examine the individual collaboration activities of members within an 
organization and their influence on firm innovation. This is surprising since several 
studies illustrate the important role individuals can play in knowledge acquisition and 
transfer processes. For instance, research on localized knowledge spillovers shows that 
individuals play an important role in the sharing of ideas and information between firms 
in regions (Saxenian, 1991; Almeida and Kogut, 1999).  The role of the individual in 
creating knowledge bridges across organizations was highlighted in the early work on 
boundary spanners (Crane, 1972; Tushman, 1977). Additionally, several studies point to 
a connection between the acquisition of scientific knowledge through collaborative 
activities and patented innovations. Cockburn and Henderson (1998) found that 
collaborations between scientists in firms and universities (as indicated by the co-
authorship of articles) increased the quality of the resulting patents. Zucker et al.  (2002) 
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show that, specifically, “star scientists” affiliated to a company (whether as employees, 
board members, founders or those linked by co-authorship to the firm) enhance the 
company's innovativeness. Rothaermel and Hess (2007) have found that non star-
scientists also have a positive influence on a firm’s innovation.  
 
In addition to this initial evidence on the importance of individual activities in firms, 
little is known about the relationship between individual- level collaboration and firm-
level characteristics. Previous studies do not clearly detangle individual collaborations 
with factors associated with individual and firm level expertise. To systematically 
evaluate whether individual (and often informal) collaborations can matter to a firm’s 
innovative output, the effects of individual collaborative activity have to be isolated by 
accounting for related factors, including the role of star scientists, the level of the firm’s 
intellectual capital, R&D investment, non-collaborative publications and strategic 
alliances. This leads to the first research question: 
 
Research Question 1: Do individual-level collaborations positively affect firm-level 
innovation and under what conditions are these collaborations important for the 
company’s innovativeness? 
 
Furthermore, keeping close to the cutting edge of technology is a daunting challenge, 
especially for small and often resource-constrained firms (Almeida and Kogut, 1997). 
Companies are faced with the challenge of not only innovating or even simply exploring 
new technological and scientific territories. They have to move beyond established 
practices and knowledge domains in order to keep close to the emerging frontiers of 
innovation. Prior research has shown that companies search for knowledge locally, i.e., 
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in the neighborhood of their past practice and their current capabilities and expertise, 
and that it is very difficult to change their technological trajectories (Nelson and Winter, 
1982). One solution might be found at the level of an individual member within the 
firm. 
 
At the individual level, scientists can reach across organizational boundaries to 
collaborate with others scientists, and this can provide the firm with useful inputs for 
innovation (Gittelman and Kogut, 2003; Cockburn and Henderson, 1998; Murray, 2002; 
Tushman, 1977). Corporate scientists belong to both organizational and scientific 
communities and, hence, facilitate the flow of knowledge between the two (Tushman, 
1977; Murray, 2002). Membership in scientific communities often gives rise to research 
collaborations between scientists (often informally) across organizational boundaries 
and results in the publication of co-authored scientific papers (Cockburn and 
Henderson, 1998). Scientists’ collaborative activities often link firms and universities 
and can, therefore, offer access to not only additional knowledge but also unique and 
early developing knowledge (Liebeskind et al.  1996).  
 
Individual- level scientific collaborations may not only lead to an increase in knowledge 
available to a firm, but, more importantly, they can facilitate insight and access to 
knowledge from a wider spectrum (geographically, organizationally, and scientifically) 
that would not be possible otherwise. Firms that have a large number of scientists 
engaged in external knowledge exchanges are, therefore, likely to be infused with a 
broad set of new ideas, decreasing the myopia (that is so often a part of the learning 
process) and consequently decreasing the resistance to change. Knowledge inputs and 
exchanges provide individuals with an early and clearer picture of the emerging 
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scientific and technological landscape, and this expands the view of scientific and 
technological possibilities available to the firm. These collaborations can, therefore, 
broaden not just the spectrum of possible scientific advances within the firm, but, just as 
important ly, the perception of what is attractive (and unattractive) to them. This leads to 
the second research question:  
 
Research Question 2: Do individual collaborations across firms (as contrasted with 
internal collaborations and strategic alliances) encourage firms to innovate in the area 
of emerging innovation? 
 
1.3 Research Setting: Biotechnology  
These hypotheses are tested in the context of the biotechnology industry because this 
sector stands out for three unique traits. First, the biotechnology industry is 
characterized by a high degree of knowledge intensity and its continuous development 
of new knowledge and innovation (Powell et al., 1996). Several studies show that the 
reliance on innovation in this industry is particularly elevated and that innovation 
ensures performance and long-term survival (Stuart, 2000; Zaheer and George, 2004; 
Shan et al.,  1994; Baum et al.,  2000). 
 
Second, biotechnology firms are strongly embedded in networks of individual and 
organizational- level collaborations, including links to other firms, universities and 
research institutes (Powell et al., 1996; Arora and Gambardella, 1990; Liebeskind et al.,  
1996). The development and commercialization of new drugs require a range of 
capabilities, including those related to basic and applied research, clinical testing, 
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production and manufacturing, marketing, distribution and managing the regulatory 
process (Powell et al., 1996). The complexity and diversity of the capabilities required 
to succeed create a division of labor between universities, pharmaceutical firms, and 
biotechnology firms. Universities and biotechnology firms tend to concentrate primarily 
on basic research and development, and pharmaceutical firms focus more on applied 
research, manufacturing, marketing and distribution (Arora and Gambardella, 1990; 
Rothaermel and Deeds, 2004). Biotechnology firms invest heavily in R&D, they often 
sponsor university research, create post-doctoral positions, and permit their scientists to 
work with relative autonomy and interact with others in the scientific community 
(Powell et al., 1996). 
 
Finally, research in the realm of innovation, learning and knowledge often faces 
problems in developing valid and reliable means to measure outputs. However, during 
the last decades, patent data has shown its usefulness in many studies on innovation, 
knowledge flows, technological development and knowledge localization (Jaffe, 1989; 
Almeida and Kogut, 1999). Patent data has the advantage that it provides systematically 
compiled and detailed information and it is continuously available over time 
(Rosenkopf and Almeida, 2003). The same can be said for academic publications as a 
source to analyze collaboration and learning activities (Gittelman and Kogut, 2003). 
Like patents, articles provide researchers with a variety of information regarding a 
certain idea or innovation; this includes the authors, their organizational affiliation, 
organizational collaboration, the organization's/authors’ address, references, and 
classification codes. Both data sources are subject to a critical review process, thus 
increasing their reliability. In terms of patents, this review is carried out by the patent 
officer, and, in the case of articles, they are approved through a peer-review process.  
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Additionally, in both cases, the information can be used to calculate advanced 
innovation and knowledge-oriented variables (e.g., patent value and technological 
scope). However, not all industries are suited to using patents (or publications) as the 
means of measurement because the propensity to use these and the motives behind their 
application vary significantly between industries (Mansfield, 1986; Cohen et al., 2000). 
Several cross- industry comparison studies reveal that drug development is among the 
industries with the highest reliance on patents. For example, in the pharmaceutical 
industry, on average, over 80% of patentable inventions are actually patented, while 
60% of already developed or commercially- introduced inventions would not have been 
developed  and 65% would not have been introduced if patent protection were not 
obtained (Mansfield, 1986). Similarly, 95.5% of firms related to drug development have 
applied for product-related patents within the last three years (Cohen et al., 2000). Even 
though these studies do not distinguish between drug development in pharmaceutical 
versus biotechnological firms, it can be assumed that the numbers are similar if not even 
higher among biotechnology firms. Biotechnology firms often don’t have any products 
on the market, and their products’ value depends on the patent pipeline (DeCarolis and 
Deeds, 1999). As a result, patents are an important instrument for these firms to protect 
and generate profits. This in turn makes the interpretation of patents more reliable in 
this industry than in others. 
 
1.5 Dissertation Structure 
The remainder of this dissertation is organized as follows. Chapter 2 provides a review 
of the relevant literature. This review is divided into three parts: First, the main 
theoretical lenses are discussed in detail, including (1) “A Behavioural Theory of the 
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Firm”, (2) Evolutionary Economics and (3) Organizational Learning. Second, the 
empirical literature on collaborative activities and innovation in regard to high 
technology industries is reviewed. Third, based on the previous literature review, the 
two research questions are derived. In Chapters 3 and 4, the two research questions are 
discussed in more detail. Chapter 3 focuses on the performance impact of individual 
collaboration, and Chapter 4 discusses how individual collaborations can influence 
corporate technological trajectories. Both of these chapters are structured like 
independent papers and include a section for hypothesis development, methodology, 
results and discussion. This separate discussion of the two research questions is justified 
for two reasons. First, even though hypothesis development addresses the logic found in 
A Behavioral Theory of the Firm (Cyert and March, 1963)the first draws more on 
arguments from Organizational Learning theories and the second from Evolutionary 
Economics (Nelson and Winter, 1982). Therefore, separate hypothesis development can 
better address the relevant theoretical issues. Second, although both questions are 
addressed in the same sample of firms, their operationalization requires the development 
of specific variables and the application of different statistical models. In the final 
chapter, the results of the two research questions are linked, and their common 
implications discussed. 
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2 LITERATURE REVIEW 
 
This chapter reviews the relevant literature and is divided into two parts. The first part 
provides an overview of the main theoretical lenses of this dissertation. It describes the 
key aspects in A Behaviorial Theory of Firm (Cyert and March, 1963) and its two 
“offspring” research streams:  Organizational Learning (Levitt and March, 1988; March, 
1991; Huber, 1991) and Evolutionary Economics (Nelson and Winter, 1982). The 
second part discusses previous empirical research relevant to the underlying research 
questions. The review of empirical research focuses on collaborative mechanisms and 
makes the distinction between organizational and individual learning to systemize 
innovation literature. As such, the review of empirical literature can be grouped along 
two dimensions derived from the theoretical part of the literature review: (1) the level of 
analysis (the organizational vs. the individual level) and (2) whether or not an activity is 
collaborative (Figure 1).1 Additionally, it is important to mention that the literature 
review in the following chapter is rather broad in its scope, referring to the general 
interest of this dissertation, the importance of individual collaboration. Chapters 3 and 4 
review the previous literature specifically for the research questions at hand. 
 
                                                 
1
 Purely organizational and internal studies are not included in the literature review because the focus of 
this dissertation is on individual collaborative innovation mechanisms. Additionally, several previous 
studies have already focused specifically on this topic.  
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Figure 1: Literature Review: Structure  
 
 
2.1 Theoretical Lenses 
Researchers use a variety of theories to explain collaborative arrangement s in firms, 
including Game Theory (Parkhe, 1993), Transaction Cost Theory (Oxley, 1997), 
Network Theory (Gulati, 1999), and  a Resource-based View of the firm (Das and Teng, 
2000; Eisenhardt and Schoonhoven, 1996). The same accounts for innovation research, 
where studies cover a wide range of fields including creativity (Amabile, 1988), 
regional or country-wide competitive advantage (Porter, 2000) and macroeconomic 
progress (Schumpeter, 1939), just to mention a few. However, when examining the 
combination or the intersection of the two research streams, two mainly dominant 
theoretical lines appear in the literature: Organizational Learning and Evolutionary 
Economics, both of which are based on the theoretical foundations outlined in A 
Behavioral Theory of the Firm (Cyert and March, 1963). Subsequently these three 
theories are explained in more detail. 
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2.1.1 A Behavioral Theory of the Firm 
A Behavioral Theory of the Firm (Cyert and March, 1963) is one of the most influential 
theories on management and organizational theory (Ramos-Rodriguez and Ruiz-
Navarro, 2004). It finds it origin in the seminal book by Cyert and March (1963), A 
Behavioral Theory of the Firm. Together with the two earlier and also very influencing 
books, Organizations (March and Simon, 1958) and Administrative Behaviour (Simon, 
1947), it serves as the cornerstone for behavioural research in management and 
organizations. The so-called “Carnegie School” in organizational theory is largely 
defined by these three books (Augier and March, 2008; Gavetti et al., 2007). 
 
The success of “A Behavioral Theory of the Firm” (Cyert and March, 1963) can be 
partly explained by the fact that it not only draws on tools, concepts and insights from 
economics and management, but also from anthropology, political science, psychology, 
and sociology to develop a realistic and applied theory of the firm. It refers to actual 
human behaviour and particularly to human decision-making in contrast to the (until 
then) idealistic view of human actions in economics and management. The key concepts 
and mechanisms it encompasses can be summarized in 7 main points (Argote and 
Greve, 2007): 
 
1. Decisions are intentionally rational but bounded by human and institutional 
limitations (bounded rationality). 
2. Organizations accumulate and use slack. 
3. Problemistic search (search in response to problems). 
4. Attent ion is a scarce resource. 
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5. Firms can be seen as coalitions of individuals and groups with conflicting goals 
in the search for dominant coalitions. 
6. The use of standard operating procedures. 
7. And firms satisfy in terms of aspiration levels and adjust these aspirations over 
time in response to experience.  
 
Many of the ideas outlined in “A Behavioral Theory of the firm ” (Cyert and March, 
1963) were introduced in the earlier work by Simon and March. For example, “bounded 
rationality” was introduced earlier by March and Simon (1958) and the concept of a 
problemistic search was based on the model of individual motivation (March and 
Simon, 1958). However, the implications of these concepts for organizational decision-
making were more fully developed by Cyert and March in 1963.   
 
By questioning the main assumption of classical economics (e.g., rationality and profit 
maximization), “A Behavioral Theory of the firm” was and still is a direct challenge to 
classical economic theorizing. As Sidney Winter (1964) noted, “this book delivers a 
major blow to that battered but hitherto unshaken intellectual construct, the theory of 
the profit-maximizing firm. Its importance derives from the fact that it presents a well-
elaborated alternative theory that stands up well under the tests of both systematic and 
causal empiricism, rather than from any novelty in the criticisms it levels against 
orthodoxy. . . Those who have not heard the distant rumblings of the ‘behavioural 
revolution’ will be surprised at the momentum it has achieved. The final verdict cannot 
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be predicted, but this book should at least convince most economists that the 
revolutionaries bear watching.” (p. 148)1 
 
The degree to which “A Behavioral Theory of the Firm” has changed economic 
reasoning is still open to debate. However, elements of a behavioural view of the firm 
can now be found in many modern developments in Economics, e.g., Transaction Cost 
Economics (Williamson, 1979; Williamson, 2000), Evolutionary Economics (Nelson 
and Winter, 1982), and Organizational Economics (Gibbons, 2005).  
 
Without doubt, the success of “A Behavioral Theory of the firm” can be found in 
management literature. The theory and some of it s direct “offspring” continue to be 
among the most influential management books and articles of all time (Ramos-
Rodriguez and Ruiz-Navarro, 2004). It has inspired and legitimated new approaches to 
studying organizations and it has become a foundational element in areas like 
population ecology, strategic management, and institutional theory and in related fields 
like political science, and sociology (Argote and Greve, 2007; Augier and March, 
2008). 
 
Argote Greve (2007) and Gavetti et al. (2007 argue that the success of “A Behavioral 
Theory of the Firm” is based on the fact that it doesn’t propose a narrow paradigm with 
strong closure properties. Instead, it is based on closely related ideas which are 
applicable to different situations. Based on the usefulness and adaptability of this 
theory’s basic assumption, its basic premises have been encompassed as foundational 
                                                 
1
 As cited in Augier and March (2008).  
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principles in several research programs in organizational studies, sociology, economics, 
and strategy. However, on the downside, its influence has been more broad than deep 
(Gavetti et al.  2007). 
 
The most direct descendents of “A Behavioral Theory of the Firm” are Organizational 
Learning Theories (Huber, 1991; March, 1991; Levitt and March, 1988) and 
Evolutionary Economics (Nelson and Winter, 1982; Nelson and Winter, 2002; Dosi and 
Marengo, 2007).1 Both research streams keep closely to the basic assumptions, 
approaches, and research questions  found in “A Behavioral Theory of the Firm”. 
(Gavetti et al., 2007; Argote and Greve, 2007). However, since most empirical research 
is embedded in either of these two research lines and does not fall under the “umbrella 
category” of the behavioural firm, they are explained in more detail below.  
 
2.1.1.1 Evolutionary Economics 
Evolutionary Economics itself has become one the most influential theory constructs in 
contemporary management and economic research (Ramos-Rodriguez and Ruiz-
Navarro, 2004) and it is particularly salient with respect to innovation research 
(Fagerberg and Verpagen, 2009). As a direct descendent, it owes many of its concepts 
and most of its philosophy to “A Behavioral Theory of the Firm” (Cyert and March, 
1963). Not only does Part II of Nelson and Winter’s (1982) book, Organization-
Theoretic Foundations of Economic Evolutionary Theory, cite many examples from the 
work carried out by Cyert, March, and Simon, but most of Evolutionary Theory 
concepts can be traced back to “A Behavioral Theory of the Firm” (Dosi and Marengo, 
                                                 
1
 It is important to note that there is no “single” Organizational Learning Theory. Organizational Learning 
research is more a collection of similar concepts and assumptions mostly related to “A Behavioral Theory 
of the Firm” (Cyert and March, 1963) 
19 
2007). For example, bounded rationality and problemistic search can be found within 
both theories. Probably the strongest link between both theories is the understanding of 
standard operating procedures or routines in order to use the language of Evolutionary 
Economics. Standard operating procedures can be seen as the predecessor of “routines” 
and thereby serve as the basis for Evolutionary Economics. Subsequently, routines 
became the foundational building blocks of research on capabilities, in general, and on 
dynamic capabilities. (Winter, 2003; Teece et al.  1997) 
 
In short, “evolutionary economics examines organizational and industrial evolution 
processes based on a model of firms as routine-based agents that change incrementally 
through search rather than as a result of optimization” (Nelson and Winter, 1982). 
Sydney Winter identifies the ten basic propositions regarding the appropriate aim of 
economic theory, the nature of firms, and the process that leads to economic growth and 
change following the evolutionary logic as follows:1 
 
1. Economic theory should reflect economic and organizational reality. Doing 
business research and doing business are not two completely different activities. 
2. Instead of focusing primarily on static equilibrium analysis, economic theory has 
to take dynamic behaviour into account.  
3. Processing information is costly. Organizations have limited time, resources and 
managerial attention. 
4. Firms are profit seekers and not profit maximizers. 
                                                 
1
 The 10-point summary is based on the work by Cohen et al. (2001) which quotes a speech by Sydney 
Winter at a special conference to honour the co-author and co-founder of Evolutionary Economics, 
Richard Nelson (Cohen et al.  2001). 
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5. Firms are not limited by a fixed set of possibilities which they can optimize. 
They can innovate and create new opportunities and possibilities.  
6. Firms are historical entities, based on stable practices (routines) which define 
their activities over time. 
7. Firms are the holders of organizational and technological knowledge and the key 
agent of change. 
8. Search processes are the basis for technological and organizational innovation. 
Therefore, the search is both internal and external, encompassing rivals, 
suppliers, customers, etc. Furthermore, the different search levels are 
interdependent. 
9. Organizational search is affected by institutions and public policy and vice- 
versa, something which leads to a co-evolutionary process between both. 
10. Market discipline and economic selection limit outcomes over time. However, 
over the short term, “anything goes”.  
 
Evolutionary Theory has a very active tradition of modelling the consequences of 
behavioural assumptions for industrial and firm evolution, and much research is 
directed to the issue of how organizations come to develop heterogeneous sets of 
capabilities and sustain (or modify) them over time (Argote and Greve, 2007). As such, 
the fundamental unit of analysis is often the routine. In the broadest sense, routines are 
“stable patterns of behaviour that characterize organizational reactions to variegated 
internal and external stimuli” (Zollo and Winter, 2002). They are the basis for 
behavioural continuity in Evolutionary Theory and led to the catch phrase, “routines as 
genes” (Nelson and Winter, 2002). Routines are the organizational analogue of skills at 
the individual level (Zollo and Winter, 2002).  
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Due to the fact that general capabilities and dynamic capabilities are based on the 
concept of organizational routine, routines are also central to research on strategic 
management. For Winter (2003), “an organizational capability is a high level routine (or 
collection of routines) that, together with its implementing input flows, confers upon an 
organization’s management a set of decision options for producing significant outputs 
of a particular type.” Dynamic capabilities are defined “as routinized activities directed 
to the development and adaptation of operating routines” (Zollo and Winter, 2002). 
Recent examples of capability-based research are: the development of dynamic 
capabilities in the Biotech industry (Rothaermel and Hess, 2007); its performance 
influence in the case of new ventures (Arthurs and Busenitz, 2006) and its development 
through alliances (Kale and Singh, 2007) and acquisitions (Ranft and Lord, 2002), just 
to name a few.  
 
A central point in Evolutionary Theory, and one which is especially relevant for this 
dissertation, is the path-dependent nature of routines (Argote and Greve, 2007). This 
means that routines develop as a function of the past. They change and adapt but they 
do so through incremental changes based on experiences and in relation to the previous 
state (Becker, 2004). Research on innovation and organizational change particularly 
relies on path dependency in its reasoning (Helfat, 1994; Stuart and Podolny, 1996; 




2.1.1.2 Organizational Learning 
The second research stream which directly uses the concepts and mechanisms  of “A 
Behavioral Theory of the Firm” is Organizational Learning (Argote and Greve, 2007). 
In their seminal work, March and Simon (1958) reject the claim of economic rationality 
and that organizational decisions are uniquely determined by environmental constraints. 
Instead, they argue that organizational behaviour depends on complex internal processes 
which add unpredictably into the decision-making process. The authors thus refer to 
several concepts which later became key to Organizational Learning (Schulz, 2002). 
Subsequently, “A Behavioral Theory of the Firm” (Cyert and March, 1963) sharpened 
the focus on organizational learning due to the authors’ perception of the firm as a 
complex adaptive system which possesses considerable autonomy against external 
events. In particular, the role of search and aspiration levels and the importance of 
routine-based behaviour are central to Organizational Learning (Gavetti et al., 2007). 
The understanding that organizational learning is slow, complex and sensitive to small 
changes during the learning process and not always performance improvements is one 
of the clearest results of the behavioural research tradition.  
 
During the last 40 years, research on organizational learning has produced an enormous 
amount of research. Some of it has become seminal in its own right and laid the 
foundation for independent research streams. For example, in his work on exploration 
and exploitation, March (1991) based his concepts directly on the work of Cyert and 
March (1963), leading to the creation of a flourishing new research stream. Similarly, 
the ideas of Communities of Practice (Brown and Duguid, 2001) and Absorptive 
Capacity (Cohen and Levinthal, 1990) build heavily on the foundation provided by A 
Behavioral Theory of the Firm. Additionally, a wide range of research on innovation, 
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product development and organizational change uses concepts from Organizational 
Learning, but without clear references to it.  
 
Several researchers have tried to systematize the vast amount of literature on 
Organizational Learning. For example, Huber (1991) tries to classify organizational 
learning in a hierarchical system with four main categories: (1) knowledge acquisition, 
(2) information distribution, (3) information interpretation and (4) organizational 
memory. Easterby-Smith et al. (2000) develop a framework for Organizational Learning 
which spans and connects the different types of learning, namely at the individual, 
group, and organizational levels. As such, Organizational Learning encompasses four 
factors: (1) processes- intuiting, (2) interpreting, (3) integrating, and (4) 
institutionalizing. Fiol and Lyles (1985) try to clarify the distinction between 
Organizational Learning and Organizational Adaptation and show that change does not 
necessarily imply learning. In a more recent review, Schultz (2002) outlines the history 
of the concept, reflects on the current debate and shows future lines of research.  
 
Two conceptual distinctions in the literature are central to frame this dissertation and 
will be used for the subsequent, more detailed empirical literature review. First, many 
researchers discuss the differences between intra-organizational learning and inter-
organizational learning  (Schulz, 2002; Dosi and Marengo, 2007) because the two 
concepts most likely involve very different learning mechanisms and problems (e.g., the 
“not invented here” syndrome). 1 
                                                 
1
 However, Argote and Greve (2007) argue that, in certain circumstances, inter and intra-organizational 
learning can be discussed together. This is because similar learning mechanisms may be found at multiple 
levels of analysis  (e.g., a myopic search may be behind imitation, and a single learning process can have 
consequences at multiple levels within organizations (Argote Greve, 2007). 
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Second, some agreement exists that Organizational Learning spans individual and 
organizational levels. However, various researchers have different views regarding the 
dominant level. It is generally accepted that individual learning is the micro unit of 
analysis for learning. As Simon (1991, p. 125) famously argues, organizational learning 
is only a metaphor because “all learning takes place inside individual human heads; an 
organisation learns in only two ways: (a) by the learning of its members, or (b) by 
ingesting new members who have knowledge the organisation previously did not have” 
(Simon, 1991). However, without denying the importance of individual learning, a 
number of authors have attempted to argue in favour of collective learning.  According 
to the collective view, organizational knowledge is not only stored in the head of 
individual members within the organization but also in (1) routines, organizational 
practices, and shared representations and (2) a set of objects and artefacts that affect 
intra-organizational relations and behaviours (Gavetti et al., 2007). Organizational 
learning is not simply the sum of each member's learning. Even though all learning 
takes place inside the human brain, it cannot be abstracted from social influences, and 
knowledge generated by the individuals does not come to bear on the organization 
independently of other individuals (Easterby-Smith et al., 2000). It is an intrinsically 
social and collective phenomena (Teece et al., 1994), and its outcome is deeply linked 
to the conditions under which it takes place (Powell et al., 1996). Organizations, unlike 
individuals, develop and maintain learning systems that not only influence their 
immediate members but are transmitted to others through organizational histories and 
norms (Fiol and Lyles, 1985). Learning enables organizations to build an organizational 
understanding and interpretation of their environment and results in associations, 
cognitive systems, and memories that are developed and shared by members of an 
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organization (Fiol and Lyles, 1985). Dosi and Marengo (2007) summarize the 
implication of the collective view of learning as follows: 
 
• Organizational learning is linked to changes in organizational practices, but 
organizational practices are not always correlated to individual knowledge.  
• Codification and interaction are the basis for all types of long- lasting 
organizational learning. 
• Instead of seeing organizational learning as purely cognitive, it is much more a 
process of social adaptation, learning and modifying organizational rules, and 
developing shared interaction patterns. 
• And organizational learning is characterized by path dependencies, whereby 
initial practices and routines shape and constrain the future activities and 
learning.  
 
2.1.2 Related Theories  
Even though Evolutionary Economics and Organizational Learning are probably the 
most dominant theory constructs to analyze collaborative activities and innovation at the 
firm level, by no means are they the only approaches. Previous research has used a 
variety of alternative theories to investigate similar research topics, including 
Transaction Cost Theory, Game Theory, and Institutional Theory. However, the most 
relevant alternative theories in regard to the underlying research question probably 
include the Resource-Based View of the Firm (Barney, 1991; Wernerfelt, 1984), the 
Knowledge-Based View of the Firm (Grant, 1996; Kogut and Zander, 1992), and 
Network Theory (Granovetter, 1985; Gulati, 1998). The Knowledge-Based View of the 
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Firm has a particularly strong link to Organizational Learning and Evolutionary 
Economics (Kogut and Zander, 1992). It is also important to mention that these theories 
are often used simultaneously and in a complementary manner to Evolutionary 
Economics and Organizational Learning to explain empirical phenomena  (Gulati, 1999; 
Brass et al., 2004; Tsai, 2001). 
 
2.2 Empirical Research on Innovation  
The second part of this literature review discusses the empirical research carried out on 
collaborative activities and  innovation with a special focus on high technology 
industries. As argued in the previous section, distinctions are made between 
organizational- level and individual- level behaviour.  
 
2.2.1 Organizational Level 
To structure the vast amount of research regarding organizational- level collaborations 
and innovation, the literature is grouped into four areas: (1) research on inter-
organizational collaboration at a dyadic level (Strategic Alliances), (2) studies 
examining organizational networks, (3) research on the absorptive capacity with respect 
to inter-organizational collaboration or networks, and (4) company-university 
collaborations as a particularly important example of organizational collaboration with 
regard to innovation in high tech industries.  
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2.2.1.1 Inter-organizational Collaboration  
Much of recent management literature focus on the learning advantages offered by 
alliances (Ahuja, 2000; Liebeskind et al., 1996; Shan et al., 1994; Shan et al., 1994). For 
example, early on Hamel et al. (1989) explained that alliances can be used as part of a 
learning strategy, and Kogut (1988) argued that alliances are formed because they help 
transfer tacit knowledge that is not easily transferred in arms- length relationships. Tacit 
knowledge is more easily transferred in alliances because the latter foster intense 
personal interaction. Grant and Baden-Fuller (2004) suggest that strategic alliances may 
be useful not just to acquire knowledge from partners, but also to exploit 
complementarities or access partner advantages. Thus, alliances may not only serve as a 
source of knowledge but also enhance the efficiency with which knowledge is applied 
in the firm. Additionally, alliances provide a platform not only to learn from partners' 
complementary knowledge, but also to learn about the partner and the knowledge 
exchange process itself (Inkpen and Dinur, 1998).  
 
Particularly in knowledge intensive industries, such as biotechnology, companies apply 
strategies that use alliances to acquire knowledge and to keep up with rapid innovations 
on a number of fronts (Powell et al., 1996). This is because knowledge components and 
parts are seen as the building blocks for innovation (Fleming, 2001; Galunic and Rodan, 
1998). Given the technological and scientific changes taking place in these industries, 
and given the resource limitations of firms, these organizations may need to follow a 
broad-based alliance strategy to avoid mediocrity.   
  
One of the first authors in the field, Arora and Gambardella (1990), explored 
organizational collaboration between firms in the biotechnology industry. They 
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demonstrated that a variety of collaborative formulas are correlated to each other and 
the authors argue that these collaborations are ways to collect distinct and 
complementary resources and capabilities. They also argue that the locus of innovation 
is in the network of inter-organizational relations and not within firms (Arora and 
Gambardella, 1990). Similar arguments are made by Rothaermel and Deeds (2004) who 
claim that the relationship between corporate alliances and new product development in 
the biotechnology field depends on a sequence of explorative and exploitative alliances. 
The development of a new product (a new drug in this case), begins with explorative 
alliances which predict the products to be developed. These explorative alliances 
subsequently predict exploitative alliances which lead to products in the market. 
Rothaermel and Deeds (2004) also show that this sequential product development 
process is moderated negatively by firm size. As firms grow, they tend to withdraw 
from product development and focus more on the discovery, development, and 
commercialization of potential projects through vertical integration (Rothaermel and 
Deeds, 2004).  
 
Investigating the relationship between technological alliances and firm performance, 
Stuart (2000) argues that alliances are “access relationships” and that their advantage 
depends on the resource profiles of the alliance partners. He shows that firms with large 
and innovative alliance partners perform better than firms without such types of partners 
and that particularly young and small firms benefit more from large and innovative 
strategic alliance partners than old and big organizations (Stuart, 2000). Similarly, 
Zaheer and George (2004) relate biotech company performance to the fact of their being 
members of an alliance cluster, but the authors also add a geographical dimension to 
their investigation. They examine to what extent it matters whether or not firms form 
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alliances with companies within their geographical proximity or if they do better by 
building alliances beyond their immediate geographical area. Their results suggest that a 
combination of both drives organizational performance. Being part of regional clusters 
is not enough; nor is it sufficient for firms to join alliance clusters. Firms gain most by a 
diversity of relationships within and beyond their geographical network (Zaheer and 
George, 2004). 
 
Focusing particularly on the effect of collaborations on new and young firms, Stuart et 
al. (2007) show that a diverse set of up and downstream alliances is particularly 
important to new and small biotech firms. Firms with multiple in- licensing agreements 
are more likely to attract alliances with downstream partners; however, the positive 
relationship between up and downstream links diminishes as firms mature (Stuart et al.,  
2007).  
 
An interesting issue is the causality between performance and collaboration, since not 
only can collaboration lead to better performance but, also, firms with high performance 
can attract more and better alliance partners. This question was central to the early work 
of Shan et al. (1994) who show that even though both relationships can be 
hypothesized, empirically, only the direction from collaboration to innovation yields 
significant results.  
 
2.2.1.2 Inter-organizational Networks  
To broaden the understanding of collaboration activities, several studies have extended 
the dyadic view of collaborations to a more network-based logic and methodology. In 
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one of the most cited studies, Powell et al. (1996) demonstrate that, in fields 
characterized by rapid technological developments (like biotechnology), the centre of 
innovation is located within the network of inter-organizational relationships. Similarly, 
Liebeskind et al. (1996) argue that biotechnology firms rely heavily on a diverse set of 
network partners. Several authors have started to examine network properties to predict 
innovation performance (Ahuja, 2000; Schilling and Phelps, 2007). Ahuja (2000) 
analyses corporate alliance networks and their influence on firm innovation in the 
chemical industry. He finds that direct and indirect ties have a positive influence on 
innovation output while structural holes have a negative one. Schilling and Phelps 
(2007) find that a dense local clustering of firms enables communication and 
collaboration between companies. Therefore, alliance networks characterized by dense 
clustering and reach increase the innovative output of firms included in these networks. 
Looking particularly at the situation of young biotech firms, Baum et al. (2000) show 
that the number of alliances and their diversity increase the initial performance of start-
ups. However, alliances with potential rivals can be harmful depending on the partners’ 
relative scope and innovativeness (Baum et al., 2000).  
 
2.2.1.3 Absorptive Capacity  
Most of the previous studies analysed the effect of collaboration independently of 
organizational factors. However, this results in an incomplete picture because several 
organizational factors might influence the innovative effect of collaborative activities. 
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As such, absorptive capacity is probably the most prominent factor investigated in 
current empirical research.1  
 
The term absorptive capacity was coined and popularized by Cohen and Levinthal 
(1990). They argue theoretically and illustrate empirically that the ability of a firm to 
recognize, assimilate and apply external knowledge is a function of the firm's prior 
knowledge base and that the development of this knowledge base is a cumulative and 
path-dependent process. Subsequently, absorptive capacity has been used in several 
studies. For example Mowery et al. (1996) show that a firm’s ability to absorb 
capabilities from its alliance partners depends on the relatedness of the firms' respective 
knowledge bases prior to the ir alliance. In a later study Mowery et al. (1998) 
demonstrate that partner selection is also related to absorptive capacity. The authors use 
patent citations to measure the technological overlap between firms before and after 
alliance formation to demonstrate partner selection and organizational change processes 
throughout the alliance.  
 
Drawing on Network Theory and the absorptive capacity concept, Tsai (2001) found 
that units within a firm improve their innovation performance if they occupy central 
network positions that provide access to knowledge developed within the firm. 
However, the positive effect depends on the organizational level of absorptive capacity. 
Without absorptive capacity firms cannot utilize the gain from their central network 
position (Tsai, 2001). Veugelers (1997) examines the two-way relationship between 
external R&D activities and internal R&D expenditures on a cross-section of Flemish 
                                                 
1
 Several other factors are shown to be important and are often used in empirical research, e.g., company 
age and size (Sorensen and Stuart, 2000; Schumpeter, 1939; Cohen and Klepper, 1996); however, 
absorptive capacity is the most important factor within the realm of this study. 
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companies. The author’s analysis boradens classical explanatory variables like size, 
diversification, ownership structure and technological opportunities to include the 
impact of various external sourcing strategies. She finds that research collaboration and, 
to a lesser extent, outsourced research have a significant positive effect on internal 
research. However, this relationship only holds if the companies have absorptive 
capacity in the form of a full-time, staffed research department. Simultaneous ly, the 
level of firms engaged in research collaborative efforts increases with internal research 
investments (Veugelers, 1997). 
 
Lane and Lubatkin (1998) criticize the initial conceptualisation of absorptive capacity 
because it implies that firms have an equal capacity to learn from all other 
organizations. Therefore, they extend the firm-level construct of absorptive capacity to 
the dyad- level construct of relative absorptive capacity. They argue that a firm’s ability 
to learn from another company depends on three points: the similarity of both firms' 
respective knowledge bases, their organizational structures and compensation policies, 
and the dominant logics. They show empirically that the similarity of the partners' basic 
knowledge, lower management formalization, research centralization, compensation 
practices, and research communities are positively related to inter-organizational 
learning. Furthermore, relative absorptive capacity shows a greater explanatory power 
than the previous measure of absorptive capacity (Lane and Lubatkin, 1998). 
Investigating degrees of similarity between partnering firms' knowledge bases, Sampson 
(2007) argues that the positive effect of alliances on innovation performance depends on 
the level of technological diversity between the two partnering companies. Alliances 
increase firms' innovative performance when technological diversity between partners is 
moderate, rather than low or high. Even though this relationship holds irrespective of 
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the alliance's organization,  the author demonstrates that hierarchical alliance structures 
(e.g., equity joint ventures) increase the benefits from alliances with high levels of 
technological diversity (Sampson, 2007). 
 
A very different approach to investigate the different roles of internal and external 
innovation mechanisms is applied by Almeida et al. (2002). Instead of looking at the 
effect of internal capabilities on external sourcing, these authors compare both internal 
and external knowledge transfers. In a sample of patent citations in the semiconductor 
industry, they show the relative superiority of intra-organizational knowledge transfers 
as compared to alliances (and markets) in cross-border knowledge-building. Building on 
a qualitative research study, they highlight the complex interplay between codified and 
tacit knowledge and the need to use different formal and informal mechanisms to build 
knowledge successfully across boarders (Almeida et al., 2002).  
 
2.2.1.4 Company-University Collaboration  
Corporate–university ventures represent a special type of organizational collaboration. 
These types of relationships have been analysed in innovation literature, particularly in 
science and technology-driven sectors. For example, several studies examine which firm 
characteristics influence the likelihood of engaging in company-university collaborative 
projects. Analysing Finnish firms, Leiponen (2001) shows that firm size and research 
skills have a positive effect on collaborations with universities (Leiponen, 2001). In a 
slightly different context Adams et al. (2000) illustrate that size and research activities 
influence whether a firm engages in relationships with federal research institutions. 
Santoro and Chakrabarti (2002) investigate the formation of corporate-university 
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collaboration projects and reveal that particularly large firms from industrial sectors 
engage in firm-university collaborations to build their competencies in non-core 
technological areas. In contrast, small firms from high tech industries concentrate more 
on problem-solving in core technological areas through technology transfers and 
collaborative research with universities (Santoro and Chakrabarti, 2002). In one of the 
most methodologically advanced studies in this area, Veugelers and Cassiman (2005) 
use instrumental variable techniques to isolate the firm's decision to engage in 
collaborative projects with universities from the company’s overall innovation strategy. 
Their analysis shows that large firms are more likely to be actively involved in industry 
science links. Additionally, the authors illustrate that these collaborations are used to 
share costs and are formed when the innovation process is not too risky. Furthermore, 
the capacity to appropriate returns from the innovation does not explain collaboration 
activities with universities (Veugelers and Cassiman, 2005).  
 
Looking directly at the benefits of firm-university collaboration Cassiman et al.  (2008) 
analyse the effect of science linkages to innovation performance at the patent level. The 
authors demonstrate that citations in scientific publications are not the main driver to 
explain forward citations, but they are positively related to the ir generality and 
geographical dispersion. Moreover, Cassiman et al. (2008) illustrate that science 
linkages at the firm level matter more for forward citations with the exception of 
emerging technologies. Particularly, non-science related patents which have no 
scientific linkage are less frequently and less easily cited than comparable patents of 
firms with science linkages (Cassiman et al., 2008). When looking at the impact of high 
level scientific output on patents, Gittleman and Kogut (2003) find that publications, 
collaborations, and science intensity are associated to patented innovations; however, 
35 
important scientific papers are negatively associated to high- impact innovations. The 
authors conclude that scientific and marketable innovations follow a different 
underlying logic and that the direct move from science to patent is more difficult and 
complex than previously assumed (Gittelman and Kogut, 2003). George et al. (2002a) 
examine the effect of science linkages on patent variables and show that firms (in the 
Biotech sector) with university linkages have lower research and development expenses 
though they have higher levels of innovative output. However, they do not find support 
for the proposition that companies with university linkages show greater financial 
performance than similar firms without such linkages (George et al., 2002a).  
 
2.2.2 Individual Level  
The role of individual activities was already highlighted in early innovation literature1 
(Crane, 1972; Tushman, 1977; Allen and Cohen, 1969). However, within the last 15 
years this topic has received more and more attention (Zucker et al., 2002; Zucker and 
Darby, 1997; Almeida and Kogut, 1999; Song et al., 2003; Rothaermel and Hess, 2007). 
This surge might be explained by the development of better databases which enable 
researchers to investigate on a more precise level. The three main areas discussed 
subsequently are boundary spanning activities, engineer mobility and the role of “Star 
Scientists”. 
 
                                                 
1
 As in the previous section, the focus lies on collaborative mechanisms; the internal factors are not 
discussed in detail.  
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2.2.2.1 Boundary Spanners 
Several of the early studies in this area could be included under the boundary spanning 
category. For example, Crane (1972) investigated the importance of individuals in 
creating knowledge bridges across organizations and the ‘invisible college of scientists’ 
that helps to diffuse knowledge within scientific communities. Her work is similar to 
related studies by Tushman (1977) and Allen and Cohen (1969) who argue about the 
positive effects of “boundary spanning” activities by certain individuals who are well-
connected internally and externally. “Boundary spanning” scientists can use their social 
ties to develop links to scientists in other firms, universities, and research institutions 
and thereby act as informal bridges across firm and geographic boundaries. 
 
2.2.2.2 Mobility  
A second research stream focusing on the external activities of individuals is  work on 
engineer and scientist mobility as a conduit for inter-firm knowledge flows. For 
example, Almeida and Kogut (1999) show the importance individuals have for the 
exchange of knowledge between firms within regions. By analyzing data on the inter-
firm mobility of patent-holders, the authors illustrate that the inter- firm mobility of 
engineers influences the local transfer of knowledge and that the flow of knowledge is 
embedded in regional labour networks (Almeida and Kogut, 1999). In a related study, 
Song et al. (2003) examine under what conditions learning-by-hiring is more likely to 
be successful. Using patent applications from software engineers who moved from US 
firms to non-US firms, the authors demonstrate that mobility is more likely to result in 
inter- firm knowledge transfers if the hiring firm is less path dependent, if the hired 
engineers possess technological expertise distinct from that found in the hiring firm, and 
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if the hired engineers work in non-core technological areas in their new firm. They also 
demonstrate that domestic mobility and international mobility are similarly beneficial to 
learning-by-hiring (Song et al., 2003). In a very recent study Corredoira and Rosenkopf 
(2010) show that not only does the hiring firm gain access to knowledge in the firm 
from which it hired the employee, but, also, the firm losing the employee is more likely 
to access knowledge from their former employee’s new employer. They find that firms 
losing employees are more likely to subsequently cite patents from firms hiring their old 
employees, thus suggesting that mobility-driven knowledge flows are bi-directional. 
Furthermore, outbound mobility is a particularly relevant knowledge channel between 
geographically distant firms, but its importance decreases for geographically proximate 
firms since other knowledge channels exist within regions  (Corredoira and Rosenkopf, 
2010). 
 
2.2.2.3 Star Scientists   
Similarly, though not explicitly, work on “star scientists” in the biotechnology field 
(and in other industries) makes several references to individual collaboration because 
these “stars” are often located in universities. In a series of papers, Lynne Zucker and 
Michael Darby together with other colleagues examine the importance star scientists 
have for innovation in firms. These stars are seen as a particularly important group of 
individuals. They show that collaborative activities with star scientists have a 
significant, positive effect on a wide range of performance measures, e.g., newly 
generated patents and products (Zucker et al., 1998; Zucker et al., 2002). The location 
of star scientists also predicts the location of firms which enter into new technology 
fields (both new and existing firms), as shown in studies on US and Japanese 
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biotechnology firms (Zucker et al., 1998). Additionally, the quality of an academic 
researcher’s scholarly output positively predicts his/her relevance to commercialization, 
to the number of collaborative projects with firms and the probability that another star 
will begin working with the firm (Zucker et al., 2002). The relationship between star 
scientists and innovation performance has also been successfully replicated for the 
semiconductor industry in the US (Torero et al., 2001).  
 
However, Rothaermel and Hess (2007) argue in a recent study that the positive effect of 
star scientists on patenting can be primarily attributed to non-star scientists and that star 
scientists do not have a significant effect on patenting. This is determined when both 
types of scientists are included in the same regression model (something not done by 
Zucker and colleagues). However, Rothaermel and Hess argue that the tension can be 
reconciled by the finding that non-star star scientists fully mediate the effect of star 
scient ists on innovative performance. Baba et al. (2009) obtain similar results in the 
photo catalysis industry in Japan by differentiating between four types of researchers in 
company-university collaborative initiatives (Edison, Pasteur, Star and Bohr type 
scientists). Only research collaborations with “Pasteur type scientists” increase a firms’ 
R&D productivity. Contrarily, collaborations with “Star scientists” have little impact on 
companies’ innovative output (Baba et al., 2009). 
 
An explanation to the at best mixed findings regarding the performance implication of 
Firm university collaborations of the previous studies is provided by Murry (2002). 
Similar to others (Gittelman and Kogut, 2003) she argues that the underlying social 
structures are very different between “science” and “technology, but that both co-evolve 
and advance. Furthermore, she shows empirically that neither co-publishing nor citation 
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as predicted from current literature drives performance, it is rather the co-mingling 
through founding, licensing and consulting (Murray, 2002). 
 
2.2.3 Combination of Individual and Organizational Levels 
The previous section shows that individual and organizational factors are primarily 
discussed separately in the literature. However, recent theoretical contributions (Felin 
and Hesterly, 2007; Hagedoorn, 2006; Brass et al., 2004) argue in favour of the 
simultaneous research of different organizational levels. All these studies identify two 
serious problems with the dominant single- level research approach. First, focusing on 
only one level of analysis implicitly assumes that most of the heterogeneity is located at 
the level of research, while alternative levels of analysis are considered to be relatively 
more homogeneous. Second, by focusing on only one  level of analysis, researchers 
implicitly assume that the different levels of analysis are independent of each other. 
Both assumptions (homogeneity in, and independence of alternative levels of analysis) 
present serious problems which can lead to spurious empirical findings (Felin and 
Hesterly, 2007; Rothaermel and Hess, 2007). 
 
A limited number of studies have started to address this issue. In two related papers Lori 
Rosenkopf and Paul Almeida compare the effect of individual mobility and 
organizational alliances. Rosenkopf and Almeida (2003) demonstrate how the mobility 
of inventors and alliances in the semiconductor industry can be used to facilitate inter-
firm knowledge flows. The authors find that the usefulness of mobility and alliances 
increases with technological distance and that mobility specifically increases inter- firm 
knowledge flows regardless of geographic proximity (Rosenkopf and Almeida, 2003). 
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In a related study using a similar dataset, Almeida et al. (2003) show that the 
effectiveness of external learning increases with start-up sized companies; however, 
differences exist between formal and informal mechanisms. Firms learn from alliances 
regardless of their size. However, for more informal mechanisms, like mobility and 
geographic co- location, learning decreases with firm size (Almeida et al.,  2003).  
 
Regardless, even though these two studies compare different levels, they still do not 
interact them. This is done by Rothaermel and Hess (2007) who simultaneously assess 
the effects of antecedents at the individual, firm, and network levels on innovation 
output. First, they look at the direct effect of these different levels and, second, they 
look at the interaction between the  different levels. In general, they find evidence that 
innovation antecedents can be found across different levels and that they can have 
compensating or reinforcing effects on firm-level innovative output. The authors show 
that the individual- level antecedents of innovation are substitutes for firm- and network-
level antecedents and that the firm-level and network- level antecedents serve as 
complements to each other (Rothaermel and Hess, 2007). Rothaermel and Hess (2007), 
Rosenkopf and Almeida (2003), and Almeida et al. (2003) clearly show that the 
combined investigation of individual and organizational- level factors is important when 
attempting to explain innovation within firms.  
 
2.4 Research Gap  
The previous literature review represents a summary of the most important studies in 
the field of inter-organizational collaboration and individual activities with respect to 
innovation. This review is structured along two dimensions_ (1) the level of analysis  
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(the organizational vs. the individual level) and (2) whether or not an activity is 
collaborative. The previous literature reviewed can be added to a matrix consisting of 
both dimensions (Figure 2). 
 
Figure 2: Literature Review: Overview  
 
 
Compared to the organizational level, only very few studies address the question of 
individual collaborative activities and their influence on organizational- level innovation, 
and even less examine collaborative activities with respect to firm-level innovation.  For 
example, though the research on engineer mobility focuses on external individual 
activities and links it to firm-level outcomes, this does not represent a collaborative 
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activity per se. Research on star scientists, for example, often assumes that these 
researchers are located in external institutions but these studies seldom directly test this 
assumption in their operationalization. Even if this factor is considered, most studies do 
not examine the role of non-star scientist collaboration and thereby offer an 
underspecified model (Rothaermel and Hess, 2007; Zucker et al., 2002). Therefore, the 
effect of individual collaboration is not isolated. Research on boundary spanners is 
probably mostly closely related to the direct investigation of individual collaboration. 
However, it often focuses on the role  and characteristics of these boundary spanners 
(Tushman and Scanlan, 1981), their influence and knowledge diffusion (Tushman, 
1977) and less on firm-level performance. Additionally, these studies could be greatly 
enriched by a more fine-tuned empirical analysis which is now possible due to new 
databases on innovation related activities.  
 
The study which probably most closely examines individual collaboration and firm-
level outcomes with respect to innovation is Cockburn and Henderson's work (1998). 
These authors analyse the link between for-profit and publicly funded research in 
pharmaceuticals via the co-authorship of scientific papers between company scientists 
and publicly funded researchers, demonstrating that these relationships increased the 
quality of the firm’s resulting patents (Cockburn and Henderson, 1998). However, and 
despite the great contribution of this study, several questions have not been addressed. 
Besides using a very small sample, the study does not control for several important 
factors (e.g., star scientists and strategic alliances), and it does not examine any 
contingencies of individual collaboration. Modern patent and article databases provide 
access to new data and allow handling previously unmanageable amounts of data. 
Therefore, the objective of this dissertation is to follow up this initial attempt to explore 
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individual collaboration and further explore the relationships between individual 
collaborations and firm performance by addressing two related questions:  
 
Research Question 1: Do individual-level collaborations positively affect firm-level 
innovation and under what conditions are these collaborations important for the 
company’s innovativeness? 
 
Research Question 2: Do individual collaborations across firms (as contrasted with 
internal collaborations and strategic alliances) encourage firms to innovate in the area 
of emerging innovation? 
 
While the first question focuses on the quantitative  generation of innovation, the second 
examines whether the generated innovation is qualitative ly different  from that produced 
by other innovation mechanisms. When responding to both questions, it is important to 
consider the alternative innovation activities identified in the previous literature review, 
including internal R&D and the role of star scientists and organizational alliances to 
isolate the affect of individual collaboration.  Despite the relatedness of both research 
questions, they are discussed independently below. This is done for two reasons: First, 
even though hypothesis development is in line in both cases with the logic found in “A 
behaviour theory of the firm” (Cyert and March, 1963), the first research question 
draws more on arguments from Organizational Learning Theory while the second from 
Evolutionary Economics. A separate hypothesis development can better address the 
relevant theoretical issues at hand. Second, although both questions are focused on the 
biotech industry, their empirical operationalization requires developing specific 
variables which require different statistical models. The sequential and independent  
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discussion offered by this methodology ensures a strong link between the theoretical 
model and empirical testing. 
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3  RESEARCH QUESTION 1: INDIVIDUAL 
COLLABORATION AND INNOVATION PERFORMANCE 
 
One way in which a firm can access external knowledge is by engaging in inter-
organizational  alliances (Inkpen, 1998).1 Empirical research has confirmed that 
strategic alliances are an important source of scientific and technological knowledge  
(Mowery et al., 1996; Powell et al., 1996; Ahuja, 2000) and contribute to firm success 
(Stuart, 2000). Yet, alliances are difficult to form and manage (Park and Ungson, 2001). 
Alliances are formal, legal entities that take time to establish and, being costly in terms 
of managerial time and attention, must be limited in their number, and targeted to 
specific needs. In an environment where the nature, location, and type of potential 
knowledge sources are continuously changing, firms need to develop flexible 
mechanisms of knowledge acquisition. In biotechnology,  for instance, given the 
uncertainty associated with the scientific development process and the applicability and 
usefulness of knowledge absorbed from any particular target (whether university or 
firm), it is important that firms have some flexibility in setting up, and potentially 
dissolving, the inter-organizational mechanisms that facilitate knowledge absorption.  
 
Recent research, both conceptual and empirical, suggests that knowledge flows 
facilitated by individuals are an important form of firm learning. For instance, research 
on localized knowledge spillovers shows that individuals play an important role in the 
                                                 
1
 Even though there are several possible benefits to alliance formation including gaining legitimacy or 
facilitating internationalization, I focus on their role related to knowledge acquisition.  
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sharing of ideas and information between firms (Saxenian, 1991). The role of the 
individual in creating knowledge bridges across organizations was highlighted in the 
early work of Diana Crane (1972) where she described the ‘invisible college of 
scientists’ that helped diffuse knowledge within scientific communities. This individual-
level exchange of knowledge can be expected to be particularly important in knowledge 
intensive industries. The focus on the individual as a conduit for inter-firm knowledge 
flows is also evident from the work on mobile engineers and innovation in 
semiconductors (Almeida and Kogut, 1999). 
 
In biotechnology, prior research has highlighted the role played by individuals (mostly 
scientists) in facilitating knowledge flows across organizations. These studies point to a 
connection between the acquisition of scientific knowledge (sometimes through 
collaborative activities on papers) and patented innovations. In an important paper, 
Cockburn and Henderson (1998), examining a sample of ten pharmaceutical firms, 
found that collaborations between scientists in firms and universities (as indicated by 
co-authorship of articles) increased the quality of the resultant patents. This finding 
suggested a link between science and innovation and also pointed to the potential 
innovative benefits of scientific collaborations. Building on this research, Gittelman and 
Kogut (2003) showed that, though scientific ideas are not usually inputs to patented 
innovation, a few scientists can enhance the value of their innovative outputs by 
drawing upon their scientific knowledge. In another influential study, Zucker et al. 
(2002) focused on the impact of star scientists in the biotechnology industry and 
examined their impact on innovation performance at the firm level. They found that star 
scientists affiliated with a firm (including employees, board members, founders and 
those linked by co-authorship to the firm) enhance the innovativeness of the firm. 
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Subsequently, Rothaermel and Hess (2007) found that only a very small percentage of 
researchers can be classified as star scientists (between 0.65% and 1.78%) and they 
produce about 15% of all articles. The paper went on to examine the role of both star 
and non-star scientists on firm innovativeness. Though they did not investigate the role 
of individual collaborations, they looked at individual, firm, and network level effects 
and found that non-star scientists matter even more than star scientists to firm 
innovation.  
 
One of the many implications of the prior research is that scientific activity, does not 
always, but often can influence innovative output and that the intellectual capital of a 
firm’s scientific workforce is an important influence on innovation. Less clear is the 
relationship between individual- level scientific collaborations and firm-level 
innovation, since the ability to form and utilize these collaborations is intertwined with 
factors associated with individual and firm level expertise. It is important to shed more 
light on these collaborations and their innovative effects since they are so pervasive – 
about 70% of all scientific articles are co-authored by researchers from different 
organizations (Gittelman, 2007) – and are potentially powerful knowledge sources. To 
systematically evaluate whether individual (and often informal) collaborations can 
matter to a firm’s innovative output (critical to success in knowledge intensive 
industries), it is important to isolate the effects of collaborative activity by accounting 
for related factors including star scientists, the level of  the firm’s intellectual capital, 
R&D investment, non-collaborative publications and strategic alliances.  
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3.1 Theory and Hypothesis 
3.1.1 Individual Collaboration and Innovation 
Thus strategic alliances may be one way to access external knowledge (see Literature 
review), but they are difficult to manage and costly to maintain (Gulati and Singh, 
1998). This is especially true for small biotechnology firms that are often constrained in 
terms of their managerial and financial resources. Further, the potential sources of 
useful information and knowledge are numerous and scattered and it may not be 
possible for even large firms to form alliances to access every possible source of 
relevant knowledge (Pisano, 2002). Most firms form only a limited number of strategic 
alliances in targeted areas. According to a 2004 study by Rothaermel and Deeds, 
biotechnology firms formed an average of 8 alliances each over a 25 year period.  
 
Research suggests that an alternative mechanism of knowledge acquisition in 
biotechnology may be through communities of practice to which scientists belong 
(Liebeskind et al.  1996). These communities have a strong social dimension (common 
language and norms) that governs the flow of knowledge between researchers. 
Scientist’s in biotechnology firms can use these social communities to develop links to 
scientists in other firms, universities, and research institutions. These links act as 
informal bridges across firm and geographic boundaries (Allen and Cohen, 1969). 
Biotechnology firms usually grant their scientists a degree of autonomy to engage with 
members of the scientific community (Powell et al.  1996).  Thus, most scientists 
simultaneously belong to both organizational and scientific communities (Brown and 
Duguid, 2001) and often facilitate the flow of knowledge between the two. In 
biotechnology, these communities often give  rise to research collaborations of scientists 
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across firm boundaries. The product of these collaborations is often the publication of 
scientific papers. Why do scientists publish their research arising from individual or 
collaborative activities? Stephan (1996) points to the importance of ‘priority’ in 
scientific discovery suggesting that published papers establish the link between the 
individual and the discovery. Though organizations may or may not always incentivize 
their scientists to collaborate across firm boundaries, these collaborations provide 
individuals (and hence their organizations) with an additional source of knowledge and 
expertise, and allow insights and access to the knowledge from a wider spectrum 
(geographically, organizationally, and scientifically) than may otherwise be possible. 
Cockburn and Henderson (1998) find that in the pharmaceutical industry, 
‘connectedness’ between for-profit firms and publicly funded research increases their 
performance in drug discovery.  
 
Firms whose employees have engaged in a larger number of collaborations can be seen 
to have greater access to a common stock of community knowledge that sets the 
foundation for further knowledge development. These individual collaborations can be 
expected to enhance in-house innovative capabilities along developing technological or 
scientific trajectories, help monitor collaborative R&D processes elsewhere, and point 
the firm in the direction of future scientific research. 
 
Hypothesis 1: The innovative output of biotechnology firms increases with the total 
number of individual- level collaborations of the firm. 
 
50 
3.1.2 Individual Collaborations and Technological Alliances 
The idea that alliances can lead to inter-firm learning is well documented in the strategic 
management literature. Hamel, Doz and Prahalad (1989) explained that alliances can be 
used as part of a learning strategy. Subsequently, empirical and conceptual studies have 
supported this idea (Inkpen, 2000; Dussauge et al.  2000; Lyles and Salk, 1996). For 
example, Rosenkopf and Almeida (2003) and Mowery et al. (1996) use patent data to 
show that alliances facilitate inter- firm knowledge flows. Grant and Baden-Fuller 
(2004) suggest that strategic alliances may be useful not just for acquiring knowledge 
from partners but also for exploiting complementarities or accessing partners’ 
advantages. Thus, alliances may not only serve as a source of knowledge but also as a 
way to enhance the efficiency with which knowledge is applied within a firm. In 
biotechnology, it can be argued that strategic alliances are extremely important to the 
innovative processes of a firm. Given the rate of change in the industry and the resource 
limitations of most stand-alone biotechnology firms, biotechnology firms appear to 
follow strategies that use external alliances for knowledge acquisition to keep up with 
rapid changes in technology on a number of fronts as well as to access partners’ 
capabilities (Powell et al.  1996). Rothaermel and Deeds (2004) suggest that in 
biotechnology, alliances can play the role of enhancing exploration and exploitation1 
(the emphasis changes to the latter with increases in firm size). Baum et al. (2000) 
looked at strategic alliances formed by biotechnology start-ups in Canada and find that 
alliances provide early access to information and enhance innovative performance.  
 
                                                 
1
 I focus on strategic alliances linked to R&D and production activities since the emphasis is on product 
or process innovation.  
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The previous hypothesised that individual collaborations enhance the innovative output 
of the firm leads to questions regarding the relative roles that individual collaborations 
and strategic alliances play with respect to firm innovativeness. One line of 
argumentation could be that the two types of collaborative activities act as 
complements. The informal collaboration of scientists across organizations could serve 
to enhance the formation and exploitation of formal strategic alliances or vice versa. 
Stuart et al. (2007) find that, for biotechnology firms, the external networks of scientists 
of a firm facilitate the organizations’ ability to identify and absorb university research. 
Scientists’ connections within the research community permit them to evaluate the 
quality and potential fit of research conducted in other organizations and hence allow 
them to play a key role in evaluating biotechnology firms as potential alliance partners 
(Liebeskind et al.  1996). The trust and understanding (Zaheer et al.  1998; Brass et al.  
2004) built through informal collaborations could also enhance the management of 
these alliances making them more useful as knowledge sharing mechanisms. Further, 
individual collaborations could help a firm’s scientists scan and search the market of 
ideas and technologies beyond the firm’s reach and this knowledge combined with the 
knowledge sourced through strategic alliances1 could enhance the innovativeness of the 
firm. Rosenkopf and Almeida (2003) show that firms use informal means such as hiring 
of experts to fill gaps in their knowledge base. Perhaps informal collaborations could be 
used to complement the knowledge base acquired by more formal means.  
 
An opposing argument could be that firms may not be able to effectively employ two 
very different mechanisms for external sourcing, as they are dependent on 
                                                 
1
 Since the focus is on technological alliances, I use the terms strategic alliances and technological 
alliances interchangeably. 
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fundamentally distinct organizational capabilities and routines. Various organizational 
attributes (structure, systems, processes, culture and leadership) may align the  
organization more towards formal (strategic alliances) or informal (individual 
collaborations) forms of learning. After all, individual collaborations rise out of 
scientific communities that are characterized by unique norms and rules that are very 
different from those that lead to the formation of strategic alliances between firms 
(Gittelman and Kogut, 2003). By concentrating on one learning mechanism, firms build 
competences in one area and lose the ability to benefit from alternative forms of 
learning (Levitt and March, 1988). Proficiency in one innovation mechanism could 
impede them from developing expertise in alternative ones and therefore create 
competency traps (Levinthal and March, 1993). These arguments suggest that strategic 
alliances and individual collaborations may not play complementary roles and may in 
fact have a negative joint effect on firm innovativeness. Given the arguments, two 
competing hypotheses regarding the relationship between strategic alliances and 
individual collaborations are developed.  
 
Hypothesis 2a: The impact of individual- level collaborations on innovative output of 
the firm increases with the number of technological alliances of the firm. 
 
Hypothesis 2b: The impact of individual- level collaborations on innovative output of 
the firm decreases with the number of technological alliances of the firm. 
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3.1.3 Individual Collaborations and Regions  
The father of neo-classical economics, Alfred Marshall (1920), explained the 
agglomeration of firms in geographical space, in part, by the presence of the 
‘atmosphere’ of knowledge’. He suggested that firms are drawn to knowledge-rich 
regions and this clustering, in turn, increases the knowledge intensity of the region. 
More recently, case studies of regional clusters in Italy (Karim and Mitchell, 2000), 
Baden-Wuerttemberg in Germany (Herrigel, 1993) and Silicon Valley in the US 
(Saxenian, 1991) describe extensive intra-regional knowledge flows. In their seminal 
paper Jaffe et al. (1993) use patent citation data to show that knowledge tends to remain 
localized within geographic regions. Saxenian (1991) relates the dynamism of regions 
to the extensive networking and knowledge sharing both at the organizational level 
(between firms, universities, buyers, suppliers, and venture capitalists) and the 
individual level within the region. In general, locational proximity reduces the cost and 
increases the frequency of personal contacts, which serves to build social relationships 
between players in the region. A common thread amongst these studies is that 
individuals belonging to different institutions interact with each other locally in 
meaningful ways and hence enhance the flow of productive knowledge across regional 
organizations. 
 
Social interaction between professionals in a region may lead to formal and informal 
collaborative activity across regional organizations and may also enhance the quality of 
these collaborations. The importance of proximity to inter-organizational collaborative 
activity is highlighted by Mansfield and Lee (1996). They find that the smaller the 
distance between a firm and university, the greater is the probability that the firm and 
the individuals therein will support R&D at the university. The study suggests that firms 
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are relatively indifferent to the quality or prestige of the faculty when they fund 
university research in applied fields, so long as the university is located close to the 
firm. The importance of location to collaborative activity is not just relevant at the firm 
level but at the individual level as well. Gittelman (2007) shows that probability that 
scientists would engage in collaborations on scientific articles, decreases with 
geographic distance. The preponderance of collaborations that are regional may be 
explained by the fact that co-location helps with the frequent exchange of sensitive and 
often tacit knowledge (Maskell and Malmberg, 1999).  
 
Co-location could have a secondary benefit for collaborations – it could help regional 
scientists identify potential partners. Only individuals who are aware of the current and 
future knowledge trends will be able to select the most valuable partners. Being located 
in knowledge intensive regions exposes firms to a larger pool of potential partner and 
increases the likelihood of finding a partner that best fits their needs. Belonging to a 
knowledge intensive region also serves to increase the legitimacy and reputation of a 
scientist to potential partners. For example, Cohen and Fields (1999) commented that 
Silicon Valley’s reputation as a center of high- technology research and development 
attracts a broad variety of human and financial investment. Since one of the strongest 
advantages of regional clusters is that they permit a higher level of trust between 
individual players and build personal ties that facilitate the flow of tacit knowledge, 
being located in a knowledge-intensive region is likely to make collaborative activity 
more efficient. These arguments suggest that co- location in knowledge rich regions 
provides scientists with two collaborative advantages – first, the individuals are more 
likely to find quality research partners and second, the quality of the collaboration will 
be enhanced by local proximity.  
55 
 
Hypothesis 3: The impact of individual- level collaborations on innovative output of the 
firm increase with the strength of the regional knowledge. 
 
3.1.4 Individual Collaborations and Universities 
Public science (emanating from government laboratories, universities, and non-profit 
research centers) play an important role in the development of scientific expertise in the 
life sciences. Narin et al.(1997) find that 73% of the scientific papers cited by US 
industrial patents are from public science sources. For biotechnology, firms depend on 
public science for basic scientific research and concentrate more on applications of this 
science (MacMillan et. al., 2002). Not surprisingly, the emergence of the biotechnology 
sector was fostered, in part, by the close linkages between start-up firms and universities 
(Owen-Smith et al.  2002). Many biotechnology firms were founded by scientists from 
local universities and consequently, are located in close proximity of these universities 
and research institutions. The association between universities and firms does not stop 
there. Founders keep in close contact with universities via research collaboration and 
sponsorship of research centers. It is not uncommon, in the biotechnology sector, for 
university professors to move to research positions in firms or even hold simultaneous 
positions in both a university and a firm (Cockburn and Henderson, 1998). Hence, 
collaborations of scientists in biotechnology firms often take place with scientists from 
universities. 
 
Why are university researchers such attractive partners of scientists based in firms? 
First, companies with university linkages have lower research and development 
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expenses (than those without these linkages) and yet have higher levels of innovative  
output (George et al.  2002b). Second, research carried out within universities is often 
complementary in nature to that in firms. Universities often focus on more risky, early 
stage research with uncertain commercial value. Firms, and the scientists working for 
them, are not incentivized to do so. Collaborating with universities is therefore one way 
of accessing knowledge on emerging technologies and scientific discoveries. Third, 
collaborating with university researchers is less risky than allying with scientists in 
competing firms. Though universities may take part in the commercialization of their 
research, the academic culture and incentives follow a very different logic than firms, 
and universities are not seen as competitive or intellectual threats to firms. Finally, since 
the publication of scientific papers offers both the individual and the firm enhanced 
prestige, scientists in firms are often encouraged, directly and indirectly, to collaborate 
with their counterparts in universities (Powell et al.  1996). The knowledge gained from 
scientific collaborations impacts not just the individual’s productivity but can be passed 
on to others in the organization and can enhance the value of the firm’s innovative 
processes.  
 
Hypothesis 4: The innovative output of biotechnology firms increases with the total 




The sample consists of publicly traded, stand-alone biotechnology firms from the US 
and Europe for the years 1990 to 2003. The BioScan database is used to select the firms. 
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BioScan is an independent industry directory that provides a comprehensive range of 
company information (e.g. ownership, location, products, alliances, mergers and 
acquisitions) and is used frequently for research purposes.1 Additional biotechnology 
directories (EuropaBio and BioCom) were consulted 2  to validate the sample. Private 
firms, biotechnology divisions of large pharmaceutical companies, and research 
institutes are not included in the sample, because of lack of availability of comparable 
data. Due to the different underlying business logics and technological foundations, 
biotechnology firm specializing in services and agro-environmental biotechnology are 
also excluded from the sample. Despite focusing only upon publicly traded 
biotechnology firms, the sample is quite representative of the industry for the following 
reasons. First, within the biotechnology industry, firms often become public when they 
are small and young. Second, since financial reports provide company information for 
up to three years before they go public, it is possible  to incorporate data from firms 
when they were still private. Therefore, sample allows including firms in their early 
stages of development. The final sample includes 115 US firm and 34 European firms. 3 
 
3.2.2 Dependent Variables 
The dependent variable - innovative output - is measured as the number of patent 
families per firm per year. In the biotechnology industry, patents are considered strong 
indicators of innovative performance both within the industry and by academics because 
they are highly correlated with other performance measures, such as new product 
                                                 
1
 For example, Gittelman and Kogut (2003), Rothaermel and Hess, (2007), Zucker et al. (2002), Shan et 
al. (1994) 
2
 BIOCOM is the largest regional life science association in the world, representing more than 575 
member companies in Southern California. EuropaBio is the European Association for Bioindustries. 
3
 The sample might appear small in comparison to the number of firms in the industry. However, the 
sample size is similar to that used in comparable studies (Rothhaermel and Hess, 2007). 
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development, profitability, and market value (Cockburn and Henderson, 1998) and are 
commonly used as measures of innovative output (Ahuja, 2000; Ahuja and Katila, 
2001; Stuart, 2000; Rothaermel and Hess, 2007). 
 
One of the challenges of looking at innovation using patent data is that patenting 
systems differ across countries and it is therefore difficult to combine patent 
information from different countries. Since one innovation can lead to several patents in 
the same country or across countries, it is challenging to accurately estimate firm 
innovative output. To deal with this issue, innovation are measured by looking at patent 
families (rather then individual patents) as provided by the Derwent Innovation Index 
database.1 A patent family is a group of patents filed by the same assignee(s) based on 
the claim of an original or priority patent. It includes the original patent and every 
subsequent patent based on the original. A patent family may include multiple 
applications from several countries, since there are differences in national regulations 
defining the breadth of intellectual property (Michel and Bettels, 2001). The use of 
patent families allows to consolidate patent information across the US and Europe, 
reduces the noise in the patent data, and therefore increases the accuracy of the 
measurement of innovation. 2  
 
                                                 
1
 DWI provides access to a comprehensive database of international patent information including more 
than 20 million patent documents from 41 worldwide patent-issuing authorities including USA, France, 
Germany, UK, Japan, Australia and Spain. This database has been used in other studies particularly those 
focusing on patent family investigations (Lanjouw and Schankerman, 2004; Harhoff et al.  2003).  
2
 For a detailed description of patent family methodologies please see Dernis and Kahn (2004). 
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3.2.3 Independent Variables  
The number of strategic alliances formed by each biotechnology firm between the years 
1990 and 2002 is obtained from the BioScan database. BioScan provides detailed 
information of firm alliance activity including the name of partners, month and year of 
the collaboration announcement, and the functional area of the collaboration (e.g. R&D, 
manufacturing, marketing, clinical trails, distribution, among others). Strategic alliances 
are coded into two categories - upstream or technology oriented alliances (including 
basic research and drug discovery), and downstream or market oriented alliances 
(including those dealing with marketing, sales and distribution). To verify the coding 
procedure, a biotechnology expert independently coded a randomly selected subsample 
(15%) of alliances. The inter-rater reliability was 0.92 - well above the  conventional 
cut-off point of 0.70. Of the 804 alliances in the sample 639 (79.5%) are R&D or 
manufacturing oriented and 165 (20.5%) are marketing oriented. Since only a few firms 
form more than two alliances in any given year, Marketing Alliances and Technological 
Alliances are included as dummy variables.  
 
Individual Collaborations are captured by the extent to which a firm’s researchers 
engage in collaborative research with scientists from other institutions and is measured 
as the total number of articles (in scientific journals) co-authored by employees of the 
focal firm with employees of another organization. Publications are frequently used to 
capture the scientific activities of individuals (Cockburn and Henderson, 1998; 
Gittelman and Kogut, 2003) and are seen as reliable sources of information since they 
are subject to the critical review of colleagues and have gained approval in a peer 
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review process.1 Co-authorship typically entails face-to-face interaction, including 
extensive discussions, exchange of ideas and joint problems solving, and represents a 
considerable investment for the participants. 
 
The ISI Web of Science (ISI) is used to identify every publication authored by any 
employee (identified by the institutional affiliation of the author) of the sample firms 
from the period 1990 to 20022. Every journal within the ISI is considered as a potential 
source of publication. Any restriction that limits the number of journals or fields could 
lead to a selection bias, since the biotechnology industry is not clearly defined - it spans 
several scientific and technological areas including human and veterinarian medicine, 
biology, physics, chemistry, and informatics. Every article is examined for co-authors 
with other institutions (firms, universities, government agenc ies, and hospitals). After 
ensuring that the co-authors’ affiliated institution was not a subsidiary of the sample 
firm, each co-authored article is counted as an individual collaboration in the year of the 
publication. 3 
 
The total number of publications by a firm’s employees is an indication of the scientific 
quality of the firm. However, the primary interest is in the collaborative activity of 
scientists. In order to distinguish between the effect of general publication activity and 
that of collaborative publications, the number of Non-Collaborative Publications is 
included in the model. These publications are articles produced by researchers from a 
firm that are not co-authored by scientists from any other organization. Using this 
                                                 
1
 For more detailed information on the validity of author patterns in biotechnology, please see Rothaermel 
and Hess (2007). 
2
 The SCI  database records details of  authors, sources, keywords, and other information relating to the 
article as well as the bibliographic references and is frequently used for research of  bibliometric data. 
3
 This procedure is very similar to Cockburn and Henderson (1998). 
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approach, approximately 24,000 collaborative articles and 8,500 non-collaborative 
articles were identified. 
 
3.2.4 Control Variables  
Several control variables were included to account for field effects and heterogeneity in 
the sample.1 An important control in any study of innovation is R&D Investment by the 
focal firm. This is variable measured as the total R&D spending by each firm for the 
given year. Firm size has been shown to impact firm success in numerous previous 
studies (Cohen and Klepper, 1996; Rosenkopf and Almeida, 2003). Firm Size is 
measured as the mean number of firm employees in a given year. Sales and total assets 
data was also collected for all firms, but the number of employees is the best indicator 
of size in the biotechnology industry. Sales represent a poor measure of size as many 
small biotechnology firms do not have positive revenue streams (or have very volatile 
ones). Total assets, too, is not an ideal measure, because most valuable assets are 
intangible ones and are not captured by accounting variables. 
 
In addition to controlling for the total number of employees, it is important to 
incorporate a measure of the intellectual strength and research quality of the scientific 
workforce. The quality of scientific research of a firm can be measured by the number 
of citations to the articles produced. Therefore, the control Intellectual Capital is 
included in the model. It measured the average number of article citations per year for 
each firm. Since older articles have a greater opportunity to be cited than recent ones, 
the citation count is standardized by the number of years for which the articles could be 
                                                 
1
 I used Datastream as a source of firm information and checked this information using annual reports.  
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cited. Since acquisitions can be used as a mode of accessing external knowledge 
(Vermeulen and Barkema, 2001), a Acquisitions dummy is include in cased the focal 
firm acquired another biotechnology firm in a given year.   
 
Prior research has emphasized the role that star scientists play in innovation (Zucker et 
al.  2002; Zucker et al.  1998). I control for the number of Star Scientists for each firm 
in a given year. I followed the approach employed by Rothaermel and Hess (2007) to 
identify star scientists. I first identified every author of a published biotechnology article 
- the average article had 6.5 authors and was cited 38.3 times. Based on this 
information, I counted the number of citations received per researcher and defined star 
scientists as those scientists whose total number of citations were more than three 
standard deviations above the mean. I use the number of citations instead of the number 
of publications, because they are a better indicator of the qua lity. To improve the 
measure, I also made adjustments for the number of authors per article (since in biology 
articles often have a large number of co-authors). This  procedure led to the 
identification of 906 star scientists (1.04% of the total). These scientists were involved 
in 30.9% of all publications and accounted for 30.8% of all citations. 
 
The extent of regional knowledge spillovers is related to the total knowledge created in 
the region (Tallman and Phene, 2007). I measured Regional Knowledge by the total 
number of biotechnology patents developed in each region in the year. Regions were 
defined as countries in Europe and as states within the US.  I standardized these values 
so that the value ‘1’ represents the region richest in biotechnology knowledge and ‘0’ 
represents the region with the least knowledge. Finally, in order to control for the 
increase of patent activity in biotechnology during the last two decades (Powell and 
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Snellman, 2004) and other time varying factors that affect all firms alike (e.g. 
macroeconomic conditions and external shocks), I controlled for temporal effects. In a 
first step, I included year dummies in the analysis. However, since the time effects 
turned out to be linear, I used a single time variable instead.  
 
3.2.5 Model Specification 
The patent measure is a non-negative count variable which can be estimated by a poison 
or negative binomial regression. Since negative  binomial regression models have the 
advantage that they account for an omitted variable bias, while simultaneous ly 
estimating heterogeneity (Cameron and Trivedi, 1998) It is used instead of the poison 
regression. In order to verify the model selection I performed the likelihood-ratio test 
(of alpha) to compare the results of the negative binomial model to the poisson model. 
The test shows the appropriateness of the negative binomial model (P > 0.01). Since the 
data had an excessive number of zero values, I also assessed suitability of using a zero-
inflated negative binomial model. However, the Vuong statistic, Akaike's information 
criterion (AIC), and Bayesian information criterion (BIC) did not indicate an advantage 
to using this type of model. I used a fixed effect specification to control for unobserved 
firm heterogeneity (Green, 2003). The Hausman test indicated that the fixed effects 
model is appropriate.  
 
To account for the non-normal distribution of R&D expenses, publication activity, and 
firm size, I normalized these variables using a logarithmic scale. To ease the 
interpretation of the results and to reduce potential co-linearity, the variables were 
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mean-centered. Additionally, to control for potential simultaneity bias and to enhance 
any causality claims, all variables were lagged by two years.1 
 
3.3 Results 
3.3.1 Descriptive Statistics  
Figure 1 presents the descriptive statistics. The data reveal strong heterogeneity across 
firms. For example, the biggest firm in the sample has more then 10,000 employees 
whereas the smallest firm employs only 4 people. As expected the data show that 
individual collaborations are more numerous than strategic alliances and that firms 
engage in more technological alliances then marketing ones. On average a firm engages 
in one technological alliance every two years and one marketing alliance every 7 years.2 
In comparison, each firm engages in an average of 13 individual collaborations per year. 
In the case of individual collaborations, approximately nine out of ten (93.5%) partners 
are located in universities, hospitals, or research laboratories. The opposite is true for 
strategic alliances where only about one in eight partners (13.1%) is a university, 
hospital, or research laboratory.  
                                                 
1
 I also used lags of one, three and four years, but the results remained stable.  
2
 This number is based on the actual alliance average and not on the dummies.  
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Figure 3: Descriptive Statistics 
Variable Mean St.Dev. Min Max
Regional Knolwedge 0,444 0,367 0,000 1,000
Intellectual Capital 3,476 10,236 0,000 180,929
Star Scientist 5,579 19,428 0,000 257,000
Temporal Effects 8,503 2,888 0,000 12,000
Acquisitions 0,073 0,260 0,000 1,000
R&D investments (Ln) 9,727 1,403 0,000 13,926
Firm Size (Ln) 5,118 1,314 1,386 9,220
Marketing Alliances 0,082 0,274 0,000 1,000
Technology Alliances 0,254 0,435 0,000 1,000
Total Firm Publication (Ln) 1,734 1,454 0,000 5,991
Non Collaborative Publication (Ln) 0,808 1,033 0,000 4,477
Individual Collaboration (Ln) 1,554 1,382 0,000 5,775
Ind. Collaboration Firms (Ln) 1,158 1,231 0,000 4,997
Ind. Collaboration Univ. (Ln) 1,766 1,581 0,000 6,394  
 
Figure 2 presents the correlation matrix. Most correlations are at a moderate level with 
the exception of the publication variables. However, not all the publication variables are 
enter in the same regression model. For example, Total Publications is not used together 
with Individual Collaborations or Non-collaborative Publications. 1 
.  
                                                 
1
 I also examined the correlation matrix of the parameters of the model as obtained from the estimation 
procedure. This matrix fully determines the Variance Inflation Factor and other collinearity measures in 
linear regressions. All correlations between the parameters were at acceptable levels indicating that the 
correlations did not bias the results. 
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Figure 4: Correlation Matrix  
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14
1 Regional Knolwedge 1,00
2 Intellectual Capital 0,09 1,00
3 Star Scientist 0,24 0,22 1,00
4 Temporal Effects -0,03 -0,40 -0,07 1,00
5 Acquisitions 0,09 0,00 0,08 0,02 1,00
6 R&D investments (Ln) 0,28 0,09 0,39 0,18 0,21 1,00
7 Firm Size (Ln) 0,11 0,10 0,35 0,09 0,29 0,66 1,00
8 Marketing Alliances 0,03 -0,01 0,11 -0,08 0,10 0,15 0,16 1,00
9 Technology Alliances 0,08 0,09 0,18 -0,04 0,11 0,31 0,22 0,26 1,00
10 Total Firm Publication (Ln) 0,19 0,25 0,53 0,04 0,16 0,54 0,43 0,13 0,30 1,00
11 Non Collaborative Publication (Ln) 0,29 0,13 0,53 0,04 0,16 0,53 0,43 0,13 0,27 0,84 1,00
12 Individual Collaboration (Ln) 0,17 0,27 0,55 0,01 0,17 0,54 0,43 0,13 0,29 0,98 0,76 1,00
13 Ind. Collaboration Firms (Ln) 0,23 0,24 0,54 0,00 0,18 0,55 0,48 0,13 0,25 0,89 0,72 0,91 1,00





3.3.2 Regression Results  
Figure 3 presents the first set of regression results. In model 1, a baseline model only 
including the control variables is estimated. Intellectual Capital, Temporal Effects, Firm 
Size, Star Scientists and Acquisitions have a positive influence on innovative output.  
Surprisingly R&D Investment does not impact innovative performance. This result may 
be driven by the fact that the time- invariant differences across firms are absorbed by the 
firm fixed effects and some part of the time variant differences is picked up by the 
Temporal Effects variable.  
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Figure 5: Fixed Effect Negative Binomial Regression I 
Variables Model  1 Model  2 Model 3 Model 4 Model 5
Intelectual Capital 0,004 ** 0,004 ** 0,004 ** 0,004 * 0,003
(0,002) (0,002) (0,002) (0,002) (0,002)
Star Scientists 0,003 ** 0,003 ** 0,002 0,002 * 0,003 **
(0,001) (0,001) (0,001) (0,001) (0,001)
Temporal Effects 0,071 *** 0,074 *** 0,072 *** 0,074 *** 0,075 ***
(0,013) (0,013) (0,012) (0,012) (0,012)
Acquisitions 0,133 * 0,122 * 0,108 0,108 0,114
(0,074) (0,074) (0,073) (0,073) (0,074)
R&D Investments (Ln) 0,031 0,022 -0,004 0,001 0,020
(0,048) (0,048) (0,048) (0,049) (0,048)
Firm Size (Ln) 0,206 *** 0,205 *** 0,195 *** 0,193 *** 0,195 ***
(0,058) (0,058) (0,057) (0,057) (0,057)
Marketing Alliances 0,084 0,080 0,090 0,100
(0,074) (0,073) (0,073) (0,073)
Technology Alliances  0,105 ** 0,084 0,089 * 0,099 *
(0,052) (0,052) (0,052) (0,052)
Total Firm Publication (Ln) 0,104 ***
(0,035)
Non Collaboative Publication (Ln) -0,041
(0,043)
Individual Collaboration (Ln) 0,123 ***
(0,040)
(Individual Collaboration/Non 
Collaborative Publicaton) (Ln) 0,139 ***
(0,047)
Constant -0,727 ** -0,679 ** -0,548 * -0,575 * -0,779 **
(0,323) (0,321) (0,321) (0,325) (0,324)
AIC 34158 34155 34148 34149 34149
BIC 34192 34199 34197 34203 34197
N 971 971 971 971 971
log likelihood -2072 -2069 -2064 -2064 -2064
p>0.1*; p>0.05**; p>0.01***
Standard Errors in brackets
 
 
Next I tested for the positive effect of technological alliances on innova tion (Model 2). 
In this model I also included marketing alliances as a control. The variable 
Technological Alliances has a positive but weakly significant impact on innovation 
whereas Marketing Alliances is not significant. In model 3, the impact of Total Firm 
Publications examined the. As expected this variable is positive and strongly significant. 
Model 4 splits publication activity into non-collaborative publications and collaborative 
publications (or Individual Collaborations). Supporting Hypothesis 1, Individual 
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Collaborations has a strong positive influence on patented innovative output (p<0.01). 
The number of non-collaborative publications does not impact patenting. In order to 
further explore the relationship between the non-collaborative and collaborative 
publications, I replaced these variables in Model 5 with a ratio of the two.1 Model 5 
shows a positive and significant effect for the ratio suggesting that as firms emphasize 
publishing scientific articles through collaboration (as opposed to independently), their 
innovative output increases. These results show that even after controlling for the 
quality of a firm’s scientists (Star Scientists and Intellectual Capital), non-collaborative 
publication activity, strategic alliances (both technology an market), and R&D - 
variables that previous research has suggested may impact innovative output - the extent 
to which a firm’s scientists collaborate on articles positively influences innovative 
performance.  
 
Model 6 explores the interaction between the two collaborative modes studied - 
Individual Collaboration and Technological Alliances. The interaction term is not 
significant. Two competing arguments and hypotheses for the interaction term’s effect 
on innovation performance were proposed, but both are not supported. Neither the 
argument on the complementarity of the two collaborative modes, nor the argument 
regarding different organizational capabilities is supported. I next look at the 
relationship between regional knowledge spillovers and individual collaboration (Model 
7). The interaction variable is positive and significant (p<01) - Hypothesis 3 is 
supported.2 In knowledge rich regions, the effect of collaborations on innovation is 
                                                 
1
 The ratio was calculated as “ln (number of collaborative publications/non-collaborative publication)” 
2
 It is important to remember that Regional Knowledge is a time -invariant variable that can not be 
included as a main effect in fixed effect regression models. However, time -invariant variables can be used 
for interaction effects in fixed effect models. This is also in line with the theoretical claim; I am interested 
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enhanced. The results for the interaction terms also hold for the fully specified model 
(model 8). 
 
To test Hypothesis 4, I distinguished between the influences of collaborative 
publications with universities and those with firms. Model 9 shows that, as expected, 
only collaborations with universities has a positive and significant influence on 
innovation performance (p<0.05). Similar to the analysis of individual collaborative and 
non-collaborative publications, I use a ratio of university to firm publications to verify 
the results. The ratio variable does not support the findings of the individual effects 
(model 10).  I therefore get partial support for the idea that collaborations with 
universities are more useful than collaborations with other firms.  
                                                                                                                                               
in the joint effect of regional knowledge spillovers and individual collaborations on innovation 
performance and not on the direct effect, which is covered by the firm fixed effects. 
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Figure 6: Fixed Effect Negative Binomial Regression II 
Variables Model 6 Model 7 Model 8 Model 9 Model 10
Intelectual Capital 0,004 * 0,004 ** 0,004 ** 0,004 * 0,004 *
(0,002) (0,002) (0,002) (0,002) (0,002)
Star Scientists 0,002 * 0,001 0,001 0,002 * 0,002 *
(0,001) (0,001) (0,001) (0,001) (0,001)
Temporal Effects 0,073 *** 0,078 *** 0,077 0,069 *** 0,073 ***
(0,012) (0,012) (0,012) (0,013) (0,012)
Acquisitions 0,108 0,101 0,104 0,112 0,106
(0,073) (0,072) (0,072) (0,073) (0,073)
R&D Investments (Ln) 0,001 0,018 0,018 0,010 0,000
(0,049) (0,049) (0,049) (0,049) (0,049)
Firm Size (Ln) 0,193 *** 0,155 *** 0,156 *** 0,194 *** 0,193 ***
(0,057) (0,058) (0,058) (0,058) (0,057)
Marketing Alliances 0,092 0,091 0,096 0,087 0,092
(0,074) (0,071) (0,072) (0,073) (0,072)
Technology Alliances  0,093 0,089 * 0,103 * 0,091 * 0,083
(0,061) (0,051) (0,061) (0,052) (0,052)
Total Firm Publication (Ln)
Non Collaboative Publication (Ln) -0,041 -0,051 -0,052 -0,026 0,091 **
(0,043) (0,043) (0,043) (0,042) (0,047)
Individual Collaboration (Ln) 0,125 *** 0,121 *** 0,125 ***
(0,041) (0,040) (0,041)
(Individual Collaboration/Non 
Collaborative Publicaton) (Ln) 0,192 ****
(0,057)
Technology Alliances x Individual 
Collaboration -0,004 -0,013
(0,033) (0,032)
Regional Knowledge x Individual 
Collaboration 0,225 *** 0,230 ***
(0,086) (0,087)
Ind. Collaboration Firms (Ln) 0,006
(0,044)
Ind. Collaboration Univ.(Ln) 0,081 **
(0,039)
(Ind. Collaboration Univ./Ind. 
Collaboration Firms)(Ln) 0,019
(0,038)
Constant -0,577 * -0,574 * -0,585 * -0,602 * -0,710 **
(0,326) (0,325) (0,327) (0,327) (0,323)
AIC 34151 34145 34146 34154 34148
BIC 34210 34203 34210 34212 34206
N 971 971 971 971 971
log likelihood -2064 -2060 -2060 -2065 -2062
p>0.1*; p>0.05**; p>0.01***




3.3.3 Robustness Checks 
Stuart et al. (2007) showed that external scientific relationships can lead to more up-
stream alliances. To evaluate the relationship between strategic alliances and individual 
scientific collaborations, I analyze the extent to which alliances lead to individual 
collaborations and vice-versa. To do this, I examined how many firms are linked to the 
same partner via both collaborative modes. Of the 14,482 inter-organizational linkages 
identified for individual collaborations, only 167 are also linked by strategic alliances 
(out of 804 alliances). This minimal overlap suggests that individual collaborations and 
strategic alliances are formed independently of each other. It also does not point to any 
relationship in the knowledge generation process for the two types of collaboration. 
Further, I examined whether the overlapping collaborations are the main drivers of 
innovation output by running a separate regression model excluding the overlapping 
collaborations from the sample. There are no substantial changes to the results 
indicating that overlapping collaborations did not drive the findings.  
 
3.3.4 Field Research  
To better understand the influence of individual collaborations on innovation and to 
check some of the underlying assumptions of the model, I conducted semi-structured 
phone interviews (of about 45 minutes) with 10 senior scientific officers from firms in 
the sample (2 European and 8 US firms). Every interviewee had a Ph.D. and three had 
previously had held leading positions in university laboratories.  1  
 
                                                 
1
 The interviews are not intended to formally test the ideas and measures, but are rather a tool to better 
understand and interpret the findings.  
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The interviews confirmed the fact that individual collaborations are indeed an important 
part of the research process of biotechnology firms. When researchers need additional 
insights or knowledge inputs in areas they are investigating, they identify potential 
collaborators based on their personal and professional networks or simply based on an 
internet search. As one researcher put it, they ‘go down the list’ until a suitable 
collaborator is found. The researchers in biotechnology firms and their academic 
partners have differing motivations for collaboration. For researchers within firms, these 
collaborations are usually targeted to fill a particular knowledge gap that emerges 
during the research process. While the immediate motivation for collaboration may be 
to successfully conduct research that leads to patentable inventions, this activity often 
leads to co-authored publications as well. This may explain why such a large percentage 
of publications in scientific journals have co-authors from different organizations. Small 
firms, particularly, use publications to gain legitimacy in the scientific and investment 
community. For university researchers, individual collaborations with firms are a source 
of funding, tools, and knowledge.  
 
The interviewees suggested that firms need both individual collaborations and strategic 
alliances to enhance their knowledge.  They also highlight differences between the two. 
Individual collaborations are strongly rooted in the scientific community whereas 
strategic alliances are often driven by non-scientific managers. Furthermore, researchers 
acknowledge that individual collaborations, usually with academic researchers, stand in 
contrast to strategic alliances that are organizational in nature. Individual collaborations 
are much more informal in nature and are usually and managed and initiated by an 
individual. Individual collaborations are based on personal relationships between 
researchers, whereas strategic alliances are more formal in nature and are planned and 
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executed within the organizational bureaucracy. Individual collaborations are formed 
and managed based on the characteristics and knowledge of the individual researchers, 
while strategic alliances are based on broader organizational characteristics and 
capabilities. From the point of view of a scientist, the time and cost in building and 
maintaining strategic alliances often makes them unattractive. Scientists perceive 
individual collaborations to be faster and more flexible and hence they engage in them 
more actively.  
 
One criticism of studies using patent and bibliometric data is that they do not 
appropriately capture innovative activity of firms. However, the interviewees confirm 
the belief that the use of both sets of data is appropriate for the sample of biotechnology 
firms. Firms need to patent and publish scientific articles to protect their intellectual 
property and gain legitimacy. Particularly for small biotechnology companies that often 
have no products and markets, patents are a good indicator of innovative output, and are 
often used by potential investors to gauge the success of firms. The publication of 
scientific articles is encouraged directly and indirectly by the firm. The researchers 
interviewed, all of whom have both co-authored publications and patents, also agreed 
that co-authored publications are a good measure of the extent of individual 
collaborations and suggest that there is a direct link between success of individual 
collaborations on scientific research and subsequent patents.  
 
An interesting question is to what extent each type of collaborative relationship 
provides access to different types of knowledge. Conventional wisdom suggests that 
universities are the source of knowledge related to basic research, while firms are the 
source of more applied knowledge. The interviews suggest a muddier picture. Even 
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though it is true that most basic advances in the field are derived from university 
research, they are also a source of applied knowledge. A number of interviewees 
suggest that firms gain substantial applied knowledge oriented towards the development 
of products through collaboration with universities. 
 
3.4 Specific Discussion  
The actions of individuals are often less observable than those of firms and are therefore 
hard to track. Fortunately, individual collaborations by biotechnology (and other) 
scientists do leave a paper trail. This trail has allowed us to evaluate and illustrate the 
extent of these collaborations and their positive impact on firm innovative output. The 
empirical tests confirm the central idea of this study – that scientific collaborations of 
researchers from different organizations have a positive effect on firm level innovative 
output. Though prior research has suggested that the actions of individual scientists and 
engineers play a role in the building and circulation of knowledge, and that 
collaborative actions across organizations enhance patenting quality,  in these part of the 
thesis I did not aim to, and did not focus upon, the firm-level innovative implications of  
the combined collaborative activities of individual researchers. The  results show that 
even after controlling for factors that have been previously suggested to impact the 
innovative output of a firm, including the quality of a firm’s star and non-star scientists, 
individual- level scientific ability, strategic alliances (both technology an market), and 
R&D investment, the extent to which a firm’s scientists collaborate on scientific articles 
positively influences the firm’s innovative performance. The research thus isolates and 
highlights the role of individual level (and often informal) collaborative activity in 
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enhancing a firm-level outcome - innovativeness - critical to an organization’s success 
in high technology industries.  
 
The research finds that firms use two modes of collaboration to source of knowledge for 
innovation. The two modes span levels of analysis (individual and organizational). By 
incorporating the influence of strategic alliances, I build on a well established stream of 
research that considers the effect of collaboration at the organizational level.  I move 
beyond the emphasis on strategic alliances as collaborative mechanisms by highlighting 
the importance of individual collaborations on firm level innovation, thus highlighting 
the role of the underlying sociology of individuals in influencing observable 
organizational outcomes. In this way, I add to the growing body of research that focuses 
on the implications of phenomena such as mobility of engineers or hiring of star 
scientists. The research makes the point that it is necessary to move beyond the study of 
strategic alliances if I are to fully understand the impact of the range of collaborative 
arrangements on firm innovation.  
 
The choice of learning mechanisms between strategic alliances and individual 
collaborations may have a strategic angle as well. If both mechanisms are useful for 
learning, the use of individual collaborations may have an advantage. They are less 
easily observable and therefore, due to the causal ambiguity associated with this 
mechanism of learning, are less likely to be imitable, suggesting implications for the 
sustainability of advantages obtained by employing this mechanism.  
 
Though strategic alliances positively impact organizational innovativeness, research 
points out that these alliances are difficult to form and manage, and small firms may be 
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limited in their ability to learn in this way. Managers often see formal alliances as 
strategic learning tools and yet have difficulty fully exploiting them for success (Gulati 
and Singh, 1998). The results suggest that managers have an additional tool in their 
managerial toolbox - collaborations conducted at the individual- level. This mode of 
knowledge acquisition can significantly enhance a firm’s knowledge base and 
productivity. Individual collaborations are particularly important when they are regional 
in nature and when they link firms and universities. I do not suggest here that it is just 
easier or more likely to form individual collaborations when the scientists are co-located 
or when one belongs to a firm and the other works for a university. I suggest instead, 
that under these circumstances, collaborations once formed, are more valuable as 
learning tools and this provides an opportunity for managers of knowledge intensive 
firms. 
 
An issue worth investigating is the relative role that strategic alliances and individual 
collaborations play in the innovative process. The data suggests that these two 
collaborative mechanisms provide access to distinct knowledge pools. Approximately 
90% of strategic alliances are firm-to-firm linkages while a similar percentage of 
individual collaborations are firm-to-university (or research laboratory) linkages. This 
could suggest that these knowledge sources could play complementary roles. I 
attempted to probe this issue by investigating the interaction effect between strategic 
alliances and individual collaborations and the results reveal a non-significant value for 
this term on the dependent variable. Field research indicates that firms would like to tap 
into both sources of knowledge. Apparently firms are unable to use knowledge from 
these collaborative mechanisms in a complementary manner. An explanation to this 
conundrum may be that, given limited organizational resources for most small 
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biotechnology firms, spreading resources too thinly across collaborative mechanisms 
results in both types of collaborations under-performing. A related explanation could be 
that firms need different capabilities and routines to harness each mechanism 
effectively. For example, strategic alliances are often supported by formal 
organizational processes and structures (Dyer and Singh, 1998), whereas the interviews 
indicate that individual collaborations are much more informal in nature and enhanced 
by organizational flexibility. It may be difficult for organizations to combine the organic 
approach to manage individual collaborations with a more structured approach for 
strategic alliances.  
 
3.5 Specific Limitations 
While I have used different sets of tests to ensure the robustness of the results, some 
limitations remain. The study is focused only on one industry, which raises question 
about the generalizability of the results. The biotechnology industry is special in its 
reliance upon basic scientific research and its unique product deve lopment and approval 
process. I intend to investigate whether the results can be generalized to other high-
technology industries like the information technology and semiconductors. I also 
recognize that innovation output operationalized by patent counts is a one dimensional 
measure for innovation. However, patent counts have shown their usefulness in 
numerous previous studies and alternative innovation measures, including new products 
developed, correlate highly with the measure. Similar to patent information, article 
based measures are frequently used to measure individual collaboration. Nevertheless, 
they may under-represent the individual collaborative activity of companies, since they 
only measure the collaborations that lead to publication. 
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4 RESEARCH QUESTION 2: INDIVIDUAL 
COLLABORATION AND EMERGING INNOVATION  
 
4.1 Theory and Hypothesis 
The behavioral theory of the firm (Cyert and March, 1963; March and Simon, 1958) 
suggests that individuals are bounded rational. In the face of uncertainty and 
complexity, they do not consider, or rationally evaluate, the complete spectrum of 
choices before them. Rather, they are heavily influenced by current areas of practice and 
by historical actions when deciding on future approaches. Thus, these individual select 
actions that tend to be in the neighborhood of current practice rather than those that may 
be the most attractive in terms of future success. Nelson and Winter (1982) point out 
that organizations, like individuals, are bounded in their rationality and decision 
processes. Using this lens to explain the evolution of organizations, they suggest that 
firms are path dependent – actions (including technology development and innovation) 
tend to be along well established and familiar paths. They ascribe this to the formation 
of routines (organizational skills or habits) within the organization. These routines favor 
local search processes and make it difficult for the firm to adapt to any changes that are 
a departure from past practices and trajectories. In complex and dynamic environments, 
local search routines fail to identify the best new solution to a problem (Fleming and 
Sorenson, 2004). These insights suggest that firms may find it difficult to search for, 
and utilize knowledge in areas that are more distant from their existing areas of 
expertise and may find it challenging to move in new innovative directions.  
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A related idea that may explain why firms find it difficult to develop new areas of 
expertise comes from the knowledge based view of the firm (Grant, 1996; Kogut and 
Zander, 1992). This view suggests that firms develop expertise in many areas through 
experience. Grant (1996) defines capabilities as “a firm’s ability to perform repeatedly a 
productive task”.  Capabilities are hard to develop and do not change easily. They arise 
from an interaction of people, structure, systems, processes and culture within the firm. 
Since the sources of capabilities are complex and diffused, and capabilities are built and 
reinforced by organizational systems over time, they are both difficult to identify and 
change (causal ambiguity).  Leonard-Barton (1992) suggests that existing capabilities 
may become core rigidities that prevent firms from changing and adjusting to external 
needs. Levinthal and March (1992) point out that experiential learning within 
organizations is common but experience is a ‘poor teacher’ and may lead to myopia or 
the inability to absorb or acknowledge changes in the external environment. Therefore, 
even in a dynamic and rapidly evolving innovative environment, firms often tend to 
exploit existing capabilities and continue to innovate in areas close to their past 
expertise1.  
 
                                                 
1 The idea of a routine, arising from evolutionary economics, is related to the concept of a capability 
associated with the knowledge based view of the firm. Winter (2000) argues “An organizational 
capability is a high level routine (or collection of routines) that, together with its implementing input 
flows, confers upon an organization’s management a set of decision options for producing significant 
outputs of a particular type”.  
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Empirical research in the form of in-depth case studies and large scale quantitative 
analyses supports the idea of local search even in the face of significant environmental 
change. Siggelkow (2001) uses a longitudinal case study of Liz Claiborne to show how 
coupling between units within the firm prevented it from adapting to environmental 
change. Grant and Baden-Fuller (2004) highlight the example of Kodak to show how 
existing capabilities led to a managerial reluctance to recognize the need for change in 
the area of technological innovation during the shift from chemical to electronic based 
technologies in the photography industry. In an early study, Helfat (1994) showed that 
R&D activity does not change significantly over time for firms in the petroleum 
industry and that differences in R&D persist across firms. In a study of medical 
imaging, Martin and Mitchell (1998) show that new entrants account for most new 
design introductions – existing players made mostly incremental changes to their 
products. Sorenson and Stuart (2000) demonstrate that in the high technology industries 
(biotechnology and semiconductors) older firms are more innovative but these 
innovations tend to be more inward looking and have less relevance to the external 
environment.  
 
The above arguments suggest that firms may find it difficult to develop flexibility in 
their technological capabilities to innovate in new or emerging areas even if they see 
this as important to their success. So how can firms enhance their ability to stay abreast 
of new ideas and knowledge and, if necessary, innovate in emerging technological 
areas?  Extant research gives us some hints about how firms may acquire and utilize the 
knowledge and capabilities to facilitate technological change. The evidence is that 
external mechanisms can be used to absorb knowledge distant from a firm’s current 
expertise. Rosenkopf and Almeida (2003) show that firms can acquire knowledge from 
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geographically or technologically distant domains through alliances and mobility and 
this knowledge helps them reach beyond the localness of search processes. At the 
individual level, Song et. al. (2003) highlight both the tendency towards local search 
and point to one way overcoming it – by hiring experts from other countries and firms. 
Hiring was only useful when the new engineers and scientists were employed outside a 
firm’s core areas. At the organizational level, Karim and Mitchel (2000) show that 
acquisitions can reinforce previous business activities (resource deepening) or help them 
undertake new and ‘path-breaking’ activities (resource extending). Hence, existing 
evidence suggests that in some instances external sources may be useful in helping 
organizations adjust their technological trajectories. The studies however do not suggest 
that all mechanisms for acquiring external knowledge are useful to change a firm’s 
technological trajectory or which if any mechanisms will give the firm the flexibility to 
move towards new innovative areas in the field.  
 
The capability to move beyond a firm’s current innovation trajectories and practices is 
especially important in biotechnology. Compared to traditional pharmaceutical firms 
that have developed their competitive advantage through capabilities linked to 
medicinal chemistry, biotechnology firms usually have expertise in the rapidly evolving 
field of molecular biology. Molecular biology has opened an array of new frontiers for 
research (including genomics, proteomics, genetic engineering, and gene therapy) and 
has also led to the development of numerous technologies related to target 
identification, clinical trials, screening and bioinformatics (Pisano, 2002). The sources of 
new scientific and technological knowledge come from an array of fields and from a 
number of specialized firms, academic laboratories, government institutions from 
around the globe (Powell et al.  1996). Success in this industry can be related to 
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expertise in basic science and the development of associated technologies to test, 
develop, and commercialize scientific ideas (Bartholomew, 1997). Hence, firms need to 
gain insights and knowledge into future productive directions for research and 
continuously develop scientific, technological, and organizational capabilities to 
innovate successfully in new and emerging areas. Firms must therefore continuously 
reach across their organizational boundaries to source emerging expertise in science and 
technology to enhance the direction and quality of their innovative activities.  
 
4.1.1 Individual Collaboration and the Frontier of Innovation 
At the individual level, scientists can reach across organizational boundaries to 
collaborate with others on research activities and this can potentially provide the 
organization with useful inputs for innovation (Gittelman and Kogut, 2003; Cockburn 
and Henderson, 1998; Murray, 2002; Tushman, 1977). Since scientists belong to both 
organizational and scientific communities, they can facilitate the flow of knowledge 
between these communities (Murray, 2002). Membership in scientific communities 
often gives rise to research collaborations of scientists (often informal) across 
organizational boundaries and result in the publication of co-authored scientific papers 
(Cockburn and Henderson, 1998). Individual- level scientific collaborations do not just 
lead to an increase in knowledge available to a firm, but importantly facilitate insights 
and access to the knowledge from a wider spectrum (geographically, organizationally, 
and scientifically) than may otherwise be possible. Firms that have a large number of 
scientists engaged in external knowledge exchange are likely to be infused with a broad 
set of new ideas, decreasing myopia (that is so often a part of the learning process) and 
consequently decreasing the resistance to change. Since scientists themselves are at the 
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core of the organization, collaborative activity with those outside the organiza tion 
promotes the development of new capabilities at the individual level, and cumulatively 
at the organizational level, along directions of their emerging interest.  
 
Knowledge inputs and exchanges provide individuals with an early and clearer picture 
of the emerging scientific and technological landscape and this expands the view of 
scientific and technological possibilities available to the firm. These external individual 
collaborations can therefore extend, not just the spectrum of possible scientific advances 
within the firm, but just as importantly, the perception of what is attractive (and 
unattractive) to them. Fleming and Sorenson (2004) point out that scientific 
investigation  allows one to develop better maps of the landscape of (scientific and 
technological) possibilities being faced by an individual or organization. Additional 
scientific inputs, obtained and refined through external interaction and scientific 
collaboration allow a firm to perceive global (rather than just local) optima and hence 
broaden the search process.  
 
Previous research has pointed to the special characteristics, values, and norms of the 
scientific community (Merton, 1973; Stephan, 1996). For example, for Merton (1973) 
the norms of science and scholarship are based on four principles: universalism, 
communalism, disinterestedness and organized skepticism. These norms of the science 
community explain relatively low levels of fraud and plagiarism as compared with other 
domains (Sztompka, 2007). Knowledge obtained from a trusted partner or collaborator 
is more likely acquire saliency, to be acted upon, and influence subsequent decision 
making. Since many scientific interactions center around emerging technologies, 
approaches and ideas, the flow of knowledge within the community itself influences the 
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future innovations that will develop in the field. Membership in this community 
therefore allows for an understanding and movement towards, not just existing 
knowledge, but of future innovative areas.  
 
In sum, firms whose employees engage in a larger number of external individual level 
collaborations can be seen to have a wider and more detailed view of possible avenues 
for research, a clearer idea of the relative merits of alternative search processes within 
the organization, and greater access to a stock of emerging insights, techniques, and 
knowledge that could enable them to pursue attractive options. These firms will 
therefore not just be better equipped to overcome some of the limitations of local 
search, but also are more likely to be able to innovate in emerging and developing areas.  
 
Hypothesis 1: Firms with greater numbers of external individual collaborations are 
likely to grow more aligned to the frontier of innovation in the field. 
 
4.1.2 Strategic Alliances and the Frontier of Innovation 
The idea that alliances can lead to inter-firm learning is well documented in the strategic 
management literature. Hamel, Doz and Prahalad (1989) explained that alliances can be 
used as part of a learning strategy. Subsequently, empirical and conceptual studies have 
supported this idea (Inkpen, 2002; Doz, 1996; Stuart, 2000; Dussauge et al.  2000; Lyles 
and Salk, 1996). For example, Rosenkopf and Almeida (2003) and Mowery et al. (1996) 
use patent data to show that alliances facilitate inter-firm knowledge flows.  
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In biotechnology, it can be argued that strategic alliances are extremely important to the 
innovative processes of a firm. Given the rate of change in the industry and the resource 
limitations of most stand-alone biotechnology firms, these firms appear to follow 
strategies that use external alliances for knowledge acquisition to keep up with rapid 
changes in technology as well as to access partners’ capabilities (Powell et al.  1996). 
Rothaermel and Deeds (2004) suggest that in biotechnology alliances can play the role 
of enhancing exploration and exploitation1 (the emphasis changes to the latter with 
increases in firm size). Baum, Calabrese and Silverman (2000) look at strategic 
alliances formed by biotechnology start-ups in Canada and find that alliances provide 
access to information and enhance innovative performance.  
 
Though strategic alliances have many potential benefits, there are several reasons to 
believe that these mechanisms are used by firms to enhance existing trajectories of 
research rather than explore emerging areas that may not be close to the firm’s current 
expertise. First, alliances are difficult to manage and costly to maintain (Gulati and 
Singh, 1998). This fact is especially true for small biotechnology firms that are often 
constrained in terms of their managerial and financial resources. Since the potential 
sources of useful information and knowledge are numerous and scattered, it may not be 
possible for even large firms to form alliances to access every possible source of 
relevant knowledge (Pisano, 2002). As a result most firms form only a limited number 
of strategic alliances in targeted areas. According to a 2004 study by Rothaermel and 
Deeds, biotechnology firms formed an average of 8 alliances each over a 25 year period. 
                                                 
1
 I focus on strategic alliances linked to R&D and production activities since the emphasis is on product 
or process innovation.  
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Given that strategic alliances are relatively few, they are likely to be targeted towards 
areas of greatest perceived need.  
 
A second, related point is that strategic alliances are indeed an organizational level 
mechanism (rather than an individual level action) where critical decisions are made 
often by senior management. These actors are more closely tied to the firm’s past 
history and success and are most likely to be subject to path dependent thinking and 
decision making. As explained by behavioral theory, past success and actions are likely 
to greatly affect the decision making of these actors, making it more likely that the 
strategic direction of alliances formed will be to enhance and grow the  firm along 
existing trajectories rather than exploring new fields and approaches. Strategic alliances 
so formed will not give scientists an opportunity to reassess and recalibrate mental maps 
and are instead likely to reinforce exiting innovation directions rather than transform 
them. 
 
A third issue associated with alliances is that they are a part of an organizational and 
legal process that is time consuming and difficult to implement. Even once legally 
established, alliances formation is itself evolutionary (Doz, 1996) involving the gradual 
establishment of routines and trust across firms before they can be effective in 
knowledge sharing (Zollo et al.  2002). Hence, there is a significant time lag between 
the decision to form an alliance and the point at which they are useful in facilitating 
knowledge flows between firms. Given that (a) alliances are restricted in their number 
and breadth, (b) their formation is likely to be influenced by path-dependent processes, 
and (c) they are significant lags between the formation decision and the availability of 
knowledge form these collaborations, alliances may not be the best mechanism for 
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keeping abreast of emerging innovations in a dynamic field where the sources of new 
science and technology are diverse and changing. While strategic alliances may enhance 
a firm’s innovativeness and its ability to commercialize innovations, they are likely to 
reinforce the trajectories of existing innovation. Hence,  
 
Hypothesis 2: Firms with greater numbers of strategic alliances are likely to grow less 
aligned to the frontier of innovation in the field.  
 
4.1.3 Internal Individual Collaboration and the Frontier of Innovation 
In addition, to the use of external collaborative mechanisms like strategic alliances and 
informal scientific collaborations, internal firm practices and characteristics are likely to 
affect the likelihood that a firm will innovate in new and emerging areas. I now explore 
the role of internal individual collaborations and firm specialization on the type of 
innovation for biotechnology firms.  
 
Innovation has been described as the recombination of knowledge (Fleming and 
Sorenson, 2004). Hence, internal collaboration between members of any organization is 
likely to lead to better sharing and utilization of knowledge and more intra- firm 
learning. Collaboration of scientists within a biotechnology firm is likely to result in 
enhancing innovativeness. However, internal collaboration may also have a darker side 
to it.  Individual collaboration amongst members of the same firm while leading to the 
efficient use of existing knowledge can also simultaneously decrease the salience and 
the utilization of external knowledge. Greater interaction and discussion between 
scientists of the same firm can lead to the reinforcement of existing mental models and 
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world views and serve to enhance the value placed on what is already known within the 
firm. Further, internal collaborations are likely to positively build resources and 
capabilities along existing trajectories and hence serve to deepen the path dependence of 
the firm. Thus individual internal collaborations could consume resources and 
mindshare that could be otherwise be oriented to searching for knowledge beyond the 
boundaries of the firm. This would decrease the flexibility and motivation to explore 
new technological directions. In comparison to external scientific activities, which are 
the expression of emphasis on an external search process, internal collaborations are 
evidence of a search process based on the internal and existing knowledge base of the 
firm thereby reinforcing existing scientific processes and paths.  
 
Hypothesis 3: Firms with greater numbers of internal individual collaborations are 
likely to grow less aligned to the frontier of innovation in the field.  
 
4.1.4 Specialization and the Frontier of Innovation  
A key firm characteristic that affects the innovation process is the extent to which the 
firm is technologically specialized (or diversified). Technological specialization (or 
focus on relatively few technologies areas) allows a firm to effectively utilize scarce 
resources and build capabilities in an efficient manner along well defined and narrow 
trajectories. Investment in a few related technological areas can enable firms to benefit 
from scale economies and to move quickly down the experience curve, permitting the 
development of expertise and technological outputs more quickly than may have been 
otherwise possible.  
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While specialization can enhance a firm’s technological productivity along existing 
areas of expertise, it may also hamper a firm’s ability to explore new territories or move 
in new technological directions should the need arise. Kogut and Kim (1994) use patent 
analysis to show that expertise in particular semiconductor technological field opens 
avenues for developing technological expertise in new fields. This implies that 
specialized firms that by definition have expertise in a narrow set of fields, have fewer 
technological platforms that aid diversification in to new and emerging fields.  
 
One of the important insights arising from Cohen and Levinthal’s (1990) seminal work 
on absorptive capacity is that investments in R&D influence an organization’s ability to 
recognize potentially useful external knowledge, absorb it, and utilize this knowledge 
effectively in their own research processes. Technologically diversified firms should be 
able to recognize potentially useful knowledge pertaining to a wider range of fields than 
more specialized firms. They are also likely to have knowledge overlaps with a wider 
range of other organizations and a broader set of organizational capabilities and are 
therefore better equipped to absorb this knowledge effectively. Technologically 
diversified firms can also utilize external knowledge more effectively since they have 
greater opportunities to make knowledge combinations that allow them to innovate and 
develop expertise in new technological directions (Cohen and Levinthal, 1990). Since 
the extent of technological diversification is not just a function of technical knowledge 
but also dependent on an organization’s human resources, structure and  processes, it is 
not surprising that Cantwell and Andersen (1996) observe that the extent of 
specialization changes only gradually over time. However, technologically diverse firms 
have greater opportunities to move into emerging technological areas given the greater 
opportunities for cross-fertilization of knowledge (Granstrand, 1998; Suzuki and 
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Kodama, 2004) and they have an enhanced capability to avoid lock- in by absorbing and 
exploiting external knowledge from a variety of sources and fields (Garcia-Vega, 2006). 
Based on these arguments I suggest that specialized firms are likely to be more path 
dependent and find it more difficult to overcome local and narrow search.  
 
Hypothesis 4: Firms that are more specialized are likely to grow less aligned to the 
frontier of innovation in the field. 
 
4.1.5 Interaction Specialization and Collaborative Mechanisms 
Our previous arguments on the relationship between specialization and absorptive 
capacity suggest that the degree to which a firm is specialized will moderate the 
relationship between the various collaborative mechanisms utilized by the firm and the 
organizations ability to move in to emerging technological areas. If specialization 
reduces a firm’s ability to recognize and value external knowledge that is distant from 
current practice, it is also likely to have a negative effect on the utilization of knowledge 
absorbed from a wide variety of sources by informal scientific collaborations. The 
scientists of more specialized firms are likely to collaborate with colleagues from a 
narrower spectrum of technological areas and the resultant cumulative knowledge 
brought in by this mechanism is also likely to be less diverse (than it would be in a 
technologically diverse firm). Not only is the knowledge absorbed likely to be less 
diverse, the likelihood of its assimilation in the firm is lower since the narrower 
knowledge base of the firm, and the organization’s systems and processes may be 
unable to fully incorporate this diverse knowledge. 
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I had argued earlier that strategic alliances and internal collaborations are a product of 
path dependent and often backward looking decisions within the firm. These modes of 
collaboration further enhance the lock- in of firms along fixed technological trajectories 
and reduce the chances of the firm moving in new technological areas as opportunities 
emerge in the field. I believe that in specialized firms, with narrow areas of 
technological expertise, these tendencies towards lock-in will be further enhanced. 
 
Hypothesis 5a: Firm technological specialization dilutes the positive relationship 
between the number of external individual collaborations and alignment to the frontier 
of innovation in the field.  
 
Hypothesis 5b: Firm technological specialization enhances the negative relationship 
between the number of strategic alliances and alignment to the frontier of innovation in 
the field.  
 
Hypothesis 5c: Firm technological specialization enhances the negative relationship 
between the number of internal individual collaborations and alignment to the frontier 




The sample and some of the independent variables are the same as in the previous 
empirical investigation. However, the dependent variable, several specific independent 
variables and the model specification are quite different to the previous model. 1 
 
4.2.2 Dependent Variables 
I use the international patent classifications codes (IPC) to capture the technological 
positions (and the change of position across time) of firms in the industry. Several 
studies have highlighted the usefulness of patent measures as indicators of innovative 
activity and capabilities (Hausman et al.  1984; Ahuja, 2000). In addition, IPC codes 
have been frequently used to assess firms’ positions in technological space (Stuart and 
Podolny, 1996; Ahuja, 2000; Song et al.  2003; Rosenkopf and Almeida, 2003). 
 
The IPC scheme is a hierarchical classification system used to classify and search patent 
documents. It is useful in assessing technological positions and distances (between 
firms) since the technological classes represent conceptually distinct groups(Zeebroeck 
et al.  2006). The codes are structured at three levels – classes representing broad 
technical fields, sub classes and finally, groups (Benner and Waldfogel, 2008). The 
study suggests that each firm occupies a position in technological space that emerges 
from a variety of decisions, actions, systems, and processes within the firm and this 
position can be observed from the technological areas in which the firm innovates in at 
any point in time. The pattern associated with the change in a firm’s innovative (and 
                                                 
1
 All variables relevant for the second empirical investigation are explained in the this part of the 
dissertation. However, for the exact description of the sample please see  “3.2.1 Sample” of the previous 
section 
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technological) position over time reveals the firm’s technological trajectory. Like firms, 
the overall industry can also be seen to occupy a innovative position at a point in time 
and to follow a trajectory over time. An aggregation of the techno logical positions of all 
the firms in the industry (as revealed by the patented innovations) and the changes in 
these positions over time serves to indicate the industry’s technological position and 
trajectory. I can therefore use data on patented innovations, to study the position of a 
firm relative to the industry at any point of time and compare the trajectory of the firm 
relative to the industry over time. The comparison of the relative technological position 
of the firm to the field across time allows us to observe whether a firm is moving 
towards (or away) from the innovative frontier of the field.  
 
I use the Derwent Innovation Index database (DWI) to gather detailed patent 
information for the sample firms between the years 1990 and 2005.1 I then use the IPC 
codes (at a sub-class level) to calculate the Euclidian (Dit) distance between a firm and 
the overall field at any point of time. This technological distance is measured as 
follows:  
∑ −= 2)( ktkitit ppD  
 
where pkit represents the proportion of a patenting activity for a firm (i) in a given 
subclass (k) in year (t), and pkt estimates the proportion of patenting activity in a given 
subclass (k) of the whole industry in the year (t). K is the number of dimensions (patent 
classes). 
                                                 
1
 DWI provides access to a comprehensive database of international patent information comprising more 
than 20 million patent documents from 41 worldwide patent-issuing authorities including USA, France, 
Germany, UK, Japan, Australia  and Spain. 
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The difference between the Euclidean distance between the firm and the fie ld across 
two points in time (M) gives us an idea if a firm’s innovative position is moving closer 
or further from the innovative core of the field. Hence, M = Dt - Dt+n  where Dt  is the 
distance between the firm and the field in time t and Dt+n  is the distance at time t+n. 
Since Dt and Dt+n can range from 0 to 1, M can range from -1 to 1 where high numbers 
indicate that the firm and the field are becoming more closely aligned. I used a three 
year time period to evaluate the changes in distance between the firm and the field 
(n=3).1  
 
4.2.3 Independent Variables  
Strategic (Technological) Alliances: I identified strategic alliances between two firms 
through the patent database by identifying every case where two or more organizations 
were listed as joint assignees (or owners) of the patent at the time it was granted. I took 
into account merger and acquisition activities, subsidiary relationships, and name 
changes which could have resulted in the listing of multiple assignees but did not 
represent alliances between independent firms. The use of co-patenting as definition for 
alliances has the disadvantage that it captures only a limited set of activities as 
collaborations, because not all collaborative activities lead to co-patenting. However, it 
has the advantage that it (1) focuses very precisely on innovation related alliances, (2) 
links the innovation generating activity accurately to the participants (authors, firms), 
(3) provides a finer grained picture of collaborations by including those not available 
                                                 
1
 I use patent application dates to identify the date of the innovation. In addition to running the models for 
n=3, I performed a sensitivity analysis with n=2 and n=4. 
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from other sources, and (4) enables us to calculate input and performance measures of 
the collaborative innovation activity. I believe that the advantages of patent based 
alliances measure outweigh the disadvantages in this particularly study. 1   
 
External Individual Collaborations: This variable captures the extent to which scientists 
of a firm engage in collaborative activities with scientists from other organizations. It is 
measured as the number of articles (in scientific journals) co-authored by employees of 
the focal firm with employees of another organization. Archival data from publications 
is often used to estimate the scientific activities of individuals and is seen as a reliable 
source of information because they are subject to the critical review of colleagues and 
have gained approval in a peer review process (Gittelman and Kogut, 2003).2 I use the 
ISI Science Citation Index (SCI) to identify all publications authored by at least one 
employee of the sample firms3. I include every journal listed in the SCI in the initial 
search for articles because any restriction could lead to a selection bias. This is 
particularly relevant for the biotechnology industry, since this field spans several 
scientific and technological areas.  
 
Internal Publications: This variable measures the total number of articles published by 
individuals within the firm. External Individual Collaborations and Internal Publications 
together make up the complete set of publications of a firm. To distinguish between 
collaborative and non-collaborative internal publications, I introduce the variables 
                                                 
1
 Please see Schilling (2009) for a general discussion of the accuracy of different alliances databases. 
2
 For more detailed information on the validity of author patterns in biotechnology, please see Rothaermel 
and Hess (2007), who discuss the publication time lag, mobility of authors , and the locus of  intellectual 
property creation and appropriation. For a discussion of the drawbacks of co-author patterns see Katz and 
Martin, (1997). 
3
 The SCI  database records details of  authors, source, keywords, and other information relating to the 
article as well as the bibliographic references and is frequently used for research purposes on bibliometric 
data (e.g. Gittelman and Kogut, 2003; Ramos-Rodriguez and Ruiz-Navarro, 2004). 
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Internal Individual Collaborations and Internal Individual Publications. Internal 
Individual Publications measures  the number of singled authored publication within the 
firm and Internal Individual Collaborations measures the number of publications co-
authored by two or more scientists in the same organization. 
 
Technological Specialization: I measure the technological specialization of the firm by 
calculating the Gini coefficient and using IPC technology sub-classes. Zeebroeck et al. 
(2006) show that the Gini coefficient is the most reliable measure when trying to 
capture technological specialization with patent data. 
 
4.2.4 Control Variables  
Control Variables:  To control for the heterogeneity in the sample I include several 
control variables in the study. 1  
 
R&D Investment is an important variable in any study predicting innovation activities. 
This variable is particularly important in a study investigating the technological 
movement of firms because several studies showed the path dependency of R&D 
(Helfat, 1994; Cohen and Levinthal, 1990).  
 
Similarly, Firm Size has been shown to impact firm innovation (Cohen and Klepper, 
1996; Rosenkopf and Almeida, 2003) and can be directly linked to innovation search 
behavior (Sorensen and Stuart, 2000). Therefore, I control for size as number of 
                                                 
1
 I used Datastream as a source of firm information for most of the control variables and double checked 
it with SEC-10K forms. 
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employees in a given year. The number of employees is preferable to alterna tive 
measures for size such as total assets or sales in this industry. Sales represent a poor 
measure because biotechnology firms often do not have positive revenue streams (or 
have very volatile ones) and accounting measures may not capture the real size of small 
firms in high technology industries.  
 
Since acquisitions can be used as a mode of accessing external knowledge (Vermeulen 
and Barkema, 2001), I included a variable, Acquisitions, that indicates if the focal firm 
acquired another biotechnology firm in a given year. To capture the characteristics of 
firms that have previously been shown to be important to innovation, I introduce four 
additional controls - Intellectual Capital, Science Orientation, Relative Technological 
Advantage, and Star Scientists. The intellectual strength of the researchers involved in 
research activities could influence their capability to predict future directions of the field 
and so I control for Intellectual Capital measured as the average number of times the 
academic articles published by each firm has been cited. The Science Orientation of the 
firm could influence the direction and level of specialization of subsequent innovation, 
so I measure this as the ratio of the numbers of papers published to R&D Investments. 
The strength of a firm in a technological area could affect its subsequent  technological 
trajectory, therefore I measure the Relative Technological Advantage (RTA) of each 
firm (Zhang et al. 2007). The RTA is defined as the sum of the ratios of the share of 
firm  (i) patents falling in technology class k, over the share of all patents falling in that 
technology class, where P is the number of patents held by firm i in technology class k. 
 
RTAit ∑∑ ∑= ))/(/)/(( ktktiktikt pppp  
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Several previous studies have highlighted the role that star scientists play in the 
innovation process (Zucker et al.  2002; Zucker et al.  1998). Therefore I control for the 
number of Star Scientists for each firm in a given year.  Similar to Rothaermel and Hess 
(2007), I identify star scientists based on their publication activity.  I first identified 
every author within the sample of publication and then counted the number of citations 
received per researcher. To account for the fact that in biotechnology, articles have a 
large number of authors, I adjusted for the number of authors per article. Finally, I 
defined star scientists as those scientists whose total number of citations were more than 
three standard deviations above the mean. The number of citations is a preferable 
measure to identify star researchers to pure publication counts because citations are a 
better indicator of the quality. The procedure identifies 906 star scientists (1.04% of the 
total scientists), who are involved in 30.9% of all publications and accounted for 30.8% 
of all citations. These ratios are comparable to previous studies (Zucker et al.  2002; 
Rothaermel and Hess, 2007). 
 
4.2.5 Model Specification  
The dependent variable is truncated at 1 and -1. This would suggest the application of a 
Tobit regression. However, Tobit models have the disadvantage of being sensitive to the 
violation of their underlying assumptions (particularly normality) and they also prevent 
the use of fix-effect models to control for unobserved heterogeneity (Greene, 2003). For 
this study, the truncation is may not be a critical issue because a large number of firms 
do not change their technological profile in a particular time period and the changes are 
nearly symmetrical in both directions (mean = 0.012; mode = 0.002; skewness = 0.650; 
kurtosis = 15.415). Based on the distribution of the dependent variable, the application 
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of a Tobit regression is not advisable. Instead I apply an OLS panel regression with 
robust standard errors. This model has the advantage that I can control for unobserved 
heterogeneity via fixed effects1. 
 
To account for the non-normal distribution of R&D investment, firm size, star scientist 
and all publication variables I normalized these variables using a logarithmic scale. To 
ease the interpretation of the results and to reduce potential co- linearity, interaction 
effects are mean-centered. Additionally, since the calculation of the dependent 
variables, includes a lag of 3 years I reduce potential simultaneity bias. 
 
4.3 Results 
4.3.1 Descriptive Statistics  
Figure 7 presents the descriptive statistics and the correlation matrix. The data reveal 
strong heterogeneity across firms. For example, the biggest firm in the sample has more 
then 10,000 employees whereas the smallest firm employs only 4 people. As expected 
the data show that individual collaborations are more numerous than strategic alliances 
and non-collaborative publications. The average number of external individual 
collaborations per firm per year is 13, compared to 4 internal publication and 0.6 
strategic alliances. Of the internal publications, 26.9 percent are single authored and 
73.1 percent are co-authored. In the case of external individual collaborations, 
approximately nine out of ten (93.5%) partners are working in universities, hospitals, or 
research laboratories. The opposite is true for strategic alliances where only about one 
                                                 
1
 The Hausman test rejects the use of random effects models . 
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out of eight partners (13.1%) is a university, hospital, or research laboratory. All 
correlations are at a moderate level with the exception of the External Individual 
Collaboration and the various types of Internal Publications measures. To further asses 
the problems of multi-collinearity I calculated the Variance Inflation Factor (VIF) for a 
pooled regression. All VIF’s are at acceptable levels (<0.5) indicating that the multi-




Figure 7: Descriptive Statistics & Correlation Matrix 
Table 1: Descritpive Statistics & Correlation Matrix 
Variable Mean Std. Dev. 1 2 3 4 5 6 7 8 9 10 11 12 13 14
1 Dependent Variable 0.007 0.145
2 Time Trend 9.499 1.905 -0.076
3 RD Investments (Ln) 9.939 1.245 -0.074 0.255
4 Firm Size(Ln) 5.160 1.316 -0.102 0.081 0.663
5 Aquisition 0.102 0.367 -0.021 0.098 0.194 0.287
6 Science Intensity 0.001 0.001 -0.003 -0.124 -0.344 -0.102 -0.040
7
Relative Technological 
Advantage 2.390 1.339 0.149 0.106 -0.262 -0.058 -0.017 -0.032
8 Intellectual Capital 65.412 200.939 -0.029 -0.101 0.255 0.268 0.081 0.063 -0.185
9 Star Scientist (Ln) 4.612 24.078 -0.026 0.035 0.238 0.268 0.074 0.065 -0.100 0.472
10
External Individual 
Collaboration (Ln) 1.710 1.350 -0.070 0.338 0.542 0.424 0.195 0.168 -0.236 0.428 0.384
11 Strategic Alliances (Ln) 0.576 0.676 -0.103 0.434 0.353 0.272 0.141 -0.002 -0.142 0.087 0.185 0.438
12 Internal Publication (Ln) 0.909 1.059 -0.079 0.298 0.519 0.430 0.176 0.101 -0.184 0.345 0.333 0.763 0.421
13
Internal Individual 
Collaboration (Ln) 0.763 1.002 -0.073 0.282 0.497 0.404 0.159 0.073 -0.179 0.272 0.299 0.688 0.400 0.959
14
Internal Individual 
Publication (Ln) 0.401 0.640 -0.053 0.263 0.432 0.388 0.167 0.124 -0.111 0.401 0.348 0.696 0.416 0.755 0.598





4.3.2 Regression Results  
Figure 8 (model 1 to 4) shows the results for the OLS firm fixed effects regression 
model. In model 1, I estimate a baseline model including the control variables only. As 
expected R&D Investment has a positive effect on the dependent variable while Firm 
Size has a negative effect. Intellectual Capital, Science Intensity, Temporal Effects, 
Scientists and Acquisitions have no effect. In model 2 I add the main variables of 
interest. Supporting Hypotheses 1, 2, and 3, Strategic Alliances (p<0.001) and Internal 
Individual Collaborations (p<0.05) are negative and significant while External 
Individual Collaborations has a positive and significant effect (p<0.05). These results 
indicate that informal collaborations with individuals from other organizations help 
guide firms towards the locus of future innovation in the field, while internal 
collaborations and strategic alliances have the opposite effect. Additionally, Science 
Intensity becomes significant (p<0.01). I next add the degree of technological 
specialization to the analysis (model 3). In line with Hypothesis 4, technological 
specialization decreases the alignment with the future locus of innovation (p<0.01). The 
incorporation of technological specialization reduces the level of significance of 
Strategic Alliances (p<0.1) and External Individual Collaborations (p<0.1). Finally, in 
model 4 I include the interaction effects between the three search mechanism and 
technological specialization. The results show that technological specialization 
increases the negative effect of Strategic Alliances (p<0.05) and Internal Individual  
Collaborations (p<0.1) but does not affect External Individual Collaborations. This 




Figure 8: Firm Fixed Effect Panel Regression  
Table 2: Regresion Results  
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8
Variables B /SE B /SE B /SE B /SE B /SE B /SE B /SE B /SE
Controls 
Time Trend -0.002 0.000 0.002 0.001 0.002 0.002 0.002 0.001
0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005
RD Investments (Ln) -0.058 *** -0.064 *** -0.063 ** -0.054 *** -0.062 *** -0.059 *** -0.063 ** -0.056 ***
0.020 0.021 0.021 0.020 0.021 0.021 0.021 0.021
Firm Size(Ln) 0.041 * 0.040 * 0.042 * 0.038 * 0.041 * 0.040 * 0.043 * 0.039
0.024 0.023 0.023 0.023 0.023 0.023 0.023 0.024
Aquisition -0.013 -0.014 -0.013 -0.009 -0.013 -0.008 -0.013 -0.010
0.012 0.012 0.012 0.012 0.012 0.012 0.014 0.014
Science Intensity -10.188 -15.499 *** -16.311 *** -12.395 ** -16.151 *** -14.173 ** -16.343 *** -12.852 **
6.412 5.954 6.077 6.097 6.207 6.319 6.232 6.243
Relative Technological Advantage 0.012 0.011 0.010 0.011 0.010 0.011 0.011 0.012
0.008 0.008 0.008 0.008 0.008 0.008 0.008 0.008
Intellectual Capital 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Star Scientist (Ln) -0.002 -0.004 -0.004 -0.003 -0.004 -0.004 -0.003 -0.005
0.004 0.005 0.005 0.004 0.005 0.004 0.006 0.006
Main Effects 
 External Individual Collaboration 
(Ln) 0.031 ** 0.033 ** 0.027 0.033 ** 0.035 ** 0.035 ** 0.026
0.014 0.015 0.026 0.015 0.014 0.016 0.027
Strategic+B75 Alliances (Ln) -0.032 *** -0.021 * -0.074 ** -0.021 * -0.022 ** -0.018 * -0.067 **
0.010 0.011 0.034 0.011 0.011 0.011 0.034
Internal Publication (Ln) -0.024 ** -0.023 * -0.060 ** -0.024 * -0.064 **
0.012 0.013 0.025 0.013 0.025
Technological Specialization -0.166 *** -0.322 *** -0.165 *** -0.263 *** -0.172 *** -0.334 ***
0.059 0.097 0.059 0.076 0.061 0.102
Internal Individual Collaboration 
(Ln) -0.020 * -0.068 **
0.012 0.029
Internal Individual Publication (Ln) -0.012 -0.041
0.014 0.038
Interaction Effects 
Individual Collaboration (Ln) x 
Tech. Specialization 0.022 0.027
0.054 0.056
Strategic Alliances (Ln) x Tech. 
Specialization 0.146 ** 0.130 *
0.074 0.076
Internal Publication (Ln) x Tech. 
Specialization 0.099 * 0.108 **
0.052 0.053
Internal Individual Collaboration 
(Ln) x Tech. Specialization 0.134 **
0.061
Internal Individual Publication (Ln) 
x Tech. Specialization 0.080
0.082
Fixed Effect Yes Yes Yes Yes Yes Yes Yes Yes
Constant 0.372 *** 0.414 *** 0.405 *** 0.387 *** 0.403 *** 0.401 *** 0.407 *** 0.394 ***
0.139 0.138 0.140 0.138 0.141 0.138 0.142 0.139
0.007 0.003 0.004 0.005 0.004 0.004 0.004 0.005
N 691 691 691 691 691 691 661 661
* p<0.1; **p<0.05; p<0.01  
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4.3.3 Robustness Checks 
To examine alternative explanation and to check the robustness of the results I run 
further analyses. First, I investigate the difference between Internal Individual 
Collaborations and Internal Individual Publications. Model 5, which depicts the main 
effect of both variables, shows that only collaborative internal activities have a 
marginally significant effect on the dependent variable. Following the logic of the 
previous model,  I also run a fully specified model (Model 6), which includes all the 
interaction effects. In line with the previous models, the interaction is significant 
(p<0.05). These results indicate that Internal Individual Collaborations are the main 
driver of Internal Publications. Next, I run a sensitivity model excluding the largest firm 
from the analysis. I do this for two reasons: First, Some of the large firm relatively 
much bigger and have much more collaboration and alliances. Even though I control for 
size and transform the independent variables, these firm could have an over proportional 
influence on the results. Second, the trajectory of the field is directly influences by the 
activities of the individual firm. Event though I believe this effect is small due to the 
sample size, a regression excluding the biggest firm provides a more conservative 
estimate of the effects, because the biggest firm should be the firm were the bias is most 
severe. Model 7 and 8 shows the results for models excluding firms with more than 
3500 employees.1 The results remain stable (in comparison to model 3 and 4), which 
strengthen the results. 
 
Finally, Figure 9 presents the previous analysis in form of a firm fixed effect logit 
specification, where the dependent variable is specified as a dummy of increasing or 
                                                 
1
  I used different cut off criteria to reduce the sample but the results remained stable. The upper limit was 
calculated )3( σµ +  and the lower limit (75th percentile+3x inter quartile range). 
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decreasing fit with the innovation frontier. This analysis is more conservative than the 
OLS model, because the specification of the dependent variables only measures the 
direction of change but not the magnitude of it. As expected the results broadly support 
the previous findings, with some exceptions. The three main effects are supported in 
model 6, but in contrast to the previous analysis technological specialization (model 7) 
is not significant. Of the three interactions terms, only the effect of strategic alliances 
and technological specialization (p<0.05) on the dependent variable is significant. 
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Figure 9: Firm fixed Effect Logit Regression  
Table 3: Regresion Results  
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8
Variables B /SE B /SE B /SE B /SE B /SE B /SE B /SE B /SE
Controls 
Time Trend -0.090 -0.087 -0.082 -0.099 -0.075 -0.081 -0.081 -0.096
0.060 0.062 0.062 0.063 0.062 0.062 0.065 0.066
RD Investments (Ln) -0.282 -0.350 -0.340 -0.233 -0.341 -0.323 -0.320 -0.221
0.246 0.261 0.262 0.269 0.263 0.266 0.262 0.270
Firm Size(Ln) 0.131 0.145 0.162 0.104 0.147 0.154 0.119 0.080
0.265 0.272 0.273 0.278 0.273 0.276 0.277 0.282
Aquisition 0.143 0.121 0.085 0.095 0.093 0.131 0.051 0.047
0.250 0.251 0.253 0.252 0.251 0.254 0.269 0.269
Science Intensity -30.420 -98.465 -93.864 -48.077 -98.472 -77.827 -88.718 -46.705
127.722 142.081 141.495 141.192 145.770 141.603 141.824 142.683
Relative Technological Advantage 0.149 * 0.144 0.143 0.154 * 0.134 0.136 0.137 0.147
0.090 0.091 0.091 0.092 0.091 0.092 0.093 0.094
Intellectual Capital 0.001 0.000 0.000 0.001 0.000 0.001 0.000 0.001
0.001 0.001 0.001 0.001 0.001 0.001 0.002 0.002
Star Scientist (Ln) -0.189 -0.225 * -0.229 * -0.220 * -0.227 * -0.239 * -0.169 -0.185
0.128 0.132 0.132 0.132 0.133 0.133 0.150 0.150
Main Effects 
External Individual Collaboration 
(Ln) 0.404 ** 0.384 ** 0.320 0.369 ** 0.413 ** 0.403 ** 0.353
0.171 0.176 0.254 0.176 0.179 0.180 0.263
Strategic Alliances (Ln) -0.349 ** -0.346 * -1.193 ** -0.351 ** -0.381 ** -0.304 * -1.100 ***
0.173 0.180 0.392 0.180 0.182 0.181 0.404
Internal Publication (Ln) -0.318 * -0.329 * -0.716 ** -0.290 -0.841 **
0.175 0.179 0.326 0.181 0.333
Technological Specialization -0.137 -2.164 * -0.149 -1.300 -0.137 -2.388 **
0.821 1.164 0.824 0.944 0.828 1.204
Internal Individual Collaboration 
(Ln) -0.395 ** -0.923 ***
0.171 0.328




Individual Collaboration (Ln) x 
Tech. Specialization 0.290 0.224
0.700 0.714
Strategic+B17 Alliances (Ln) x 
Tech. Specialization 2.321 ** 2.167 **
0.991 1.028
Internal Publication (Ln) x Tech. 
Specialization 0.951 1.485 *
0.863 0.893
Internal Individual Collaboration 
(Ln) x Tech. Specialization 1.488 *
0.839
Internal Individual Publication 
(Ln) x Tech. Specialization 0.875
1.248
Fixed Effect Yes Yes Yes Yes Yes Yes Yes Yes
N 679 679 679 679 679 679 645 645
* p<0.1; **p<0.05; p<0.01  
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4.4 Specific Discussion  
This part of the dissertation examined the challenge faced by firms in dynamic and 
uncertain innovative environments to keep track of, and when strategically appropriate, 
move towards the emerging frontier of knowledge and innovation. It focuses on the 
issue of how firms can keep abreast of continuously evolving, complex, and dispersed 
knowledge, and when necessary, adjust or alter their technological and innovative 
trajectories and capabilities, to stay close to the cutting edge of the evolving field. 
Building upon concepts from evolutionary economics (Nelson and Winter, 1982) and 
the behavioral theory (Cyert and March, 1963) of the firm, I suggest that this process is 
not easily achieved, since individuals and firms alike have difficulties in rationally 
evaluating the environment and selecting the most appropriate future direction for the 
firm. Faced with uncertainty and complexity, they do not consider the complete 
spectrum of choices before them. Instead, they are heavily influenced by current areas 
of practice and by historical actions when deciding on future approaches. Thus, 
decisions and actions taken tend to be in the ne ighborhood of current practices and 
firms tend to move along existing paths even as new and possibly technologically 
distant avenues of innovative opportunity appear. Thus it is challenging for firms to 
keep up with emerging innovative frontiers especially in a dynamic technological and 
scientific field like biotechnology.  
 
This study looks not just at the challenges faced by firms but, conceptually and 
empirically, points to solutions that may be available. Organizations can choose from a 
range of mechanisms to acquire and utilize knowledge that can not only affect their 
innovativeness but also their ability to adjust their technological and innovative 
trajectories. The study compares the effect of three key collaborative mechanisms 
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related to knowledge acquisition and innovation. I suggest that the collaborations of  
individual scientists across organizations gives firms a diverse set of  knowledge inputs 
from a range of external sources and this provides early signals about various innovative 
directions of the field. The knowledge inputs so obtained and incorporated in to 
research at the individual level are less impacted by the constraining elements of the 
organization’s routines, structure and culture, and can thus help to redirect the mindset 
of decision making within the firm and reorient the innovative directions of the firms 
towards emerging innovative areas. The empirical findings support this idea. 
 
I also argue that two other collaborative mechanisms – strategic (technological) 
alliances and internal collaborations - are products of existing firm, systems, expertise 
and world view, and serve to harness knowledge that matches, or is close to, existing 
activities and trajectories. They are, therefore, likely to enhance local search and help 
harden existing innovation trajectories. In a dynamic environment, as new areas of 
innovation unfold, firms that employ these mechanisms will tend to find themselves 
drifting further away from the evolving frontier of innovation in the field. The empirical 
analysis confirms these expectations as well. Finally, I show that the level of 
technological specialization of the firm influences the breadth of the search process.  
Specialized firms are less likely to increase their alignment with the emerging center of 
innovation.  I also find that specialization reinforces the effect that strategic alliances and 
internal collaborations have on the direction of future innovation.  
 
This study seeks to build upon, and contribute to, the extant literature in strategy and 
technology in several ways. Previous research has pointed out that external knowledge 
can be useful for enhancing the level and qua lity of innovation within firms (Stuart, 
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2000; George et al.  2002b; Castellacci, 2009). The research focuses not only on testing 
the impact of external knowledge on the quality and the quantity of innovation (a 
question that has been well researched) but rather on the influences of this knowledge 
on the direction of innovation. Further, I move beyond investigating whether external 
knowledge can be used for exploration by examining the mechanisms (and conditions) 
that can lead to adjustments in the innovation profile of a firm. Finally, since in fields 
like biotechnology the locus of innovation of the field changes across time, I examine 
which firms are likely to be able to alter their innovative trajectories to keep close to the 
emerging innovative areas in the field. 
One of the main contributions of this study is that while acknowledging that 
various collaborative mechanisms can be similarly useful in determining the extent of 
knowledge acquisition and application, there are important differences in how they 
influence the direction of innovation. Strategic alliances and internal research 
collaborations may enhance innovation and be useful in extending existing innovative 
abilities, but they tend to do so along existing trajectories. Strategic alliances and 
internal collaborations are likely to be useful collaborative tools in fairly stable 
technological and innovative environments where firms can choose and build their 
abilities along predic table trajectories. External collaborations at the individual level 
may be particularly useful in dynamic and uncertain environments since they appear to 
facilitate and enhance the flexibility of firms to innovate in areas of emerging 
opportunities.  
This research builds on other recent papers that emphasize the role of 
individuals in knowledge transfer and innovation (Song et al.  2003; Zucker et al.  2002; 
Rothaermel and Hess, 2007). Individuals have been looked upon as useful conduits for 
knowledge transfer across firms, and the research confirms this perspective. It is 
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interesting to note that one of the core ideas in organizational design is that various 
intra-organizational tools and levers are used to align the incentives and actions of 
individual employees towards the main objectives of the organization. Yet I find here 
that the value of individual collaborations across organizational boundaries emerges in 
part from the fact that individuals search a diverse knowledge base and incorporate 
knowledge and insights that may not be fully aligned with the organization’s current 
way of thinking and practices. In doing so, these individual collaborations can help 
redefine the perspective of the firm, allow the firm to rethink the landscape of 
innovative possibilities, and move the innovative trajectory in new directions. 
 
An interesting issue is the contrasting effects of the two external modes of 
collaboration. Strategic alliances are formal mechanisms formed and implemented at 
multiple levels of the organization. Alliances can, therefore, be viewed essentially as 
organizational level mechanisms. Individual scientific collaborations, on the other hand, 
are often informal in nature and formed at the level of the individual scientist. Here I 
look at the contrasting effects of these mechanisms on innova tive direction. The 
research is in line with several recent theoretical and empirical studies which argue on 
the importance of a multilevel perspective when analyzing organizations (Reuer and 
Arino, 2007; Geels, 2004; Brass et al.  2004). I not only show a direct effect of 
individual actions on organizational outcomes, but also find a strong interaction effect 
between the individual and organizational level. 
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4.5 Specific Limitations 
While I have used different models and approaches to ensure the robustness of the 
results, some limitations remain. First this study is focused on a single industry, which 
raises questions about the generalizability of the results. The biotechnology industry is 
special in its reliance upon basic scientific research and its unique product development 
and approval process. Second, patent and article based measures are limited in the 
extent to which they can capture firm innovation and collaboration behavior. They may 
under-represent the individual collaborative activity of companies, since they only 
measure the collaborations that lead to publications. Nevertheless they provide one of 
the best measures currently available to empirical research and I have applied them and 





Though prior research has show, that collaborative mechanism and individual actors 
matter in the innovation process of firms only very limited research crossed both affects 
and examined the effect of individual level collaboration on firm level innovation. This 
dissertation tried to shield light on this issue by examine two fundamental questions:  
(1) Do individual-level collaborations positively affect firm-level innovation? and (2) 
Do individual collaborations across firms facilitate firms innovatingat the frontier of 
emerging? 
 
To answer the first question I used primarily organizational learning literature. I build 
on the work Cockburn and Henderson (1998), Rothermel and Hess (2007) and Zucker 
et al. (2007), who highlight the importance of individual activities in the innovation 
process, but have not been focusing on individual collaboration specifically and thus did 
not isolate the effect of individual collaboration from other innovation mechanism.  
Additionally, previous studies did  not investigate moderating factors. The results of this 
part of the dissertation shows that even after controlling for factors that have been 
suggested to impact the innovative output of a firm, (quality of a firm’s star and non-
star scientists, individual- level scientific ability, strategic alliances, and R&D 
investment) the extent to which a firm’s scientists collaborate on scientific articles 
positively influences the firm’s innovative performance. Therefore, this dissertation 
isolates and highlights the role of individual collaborative activity in enhancing a firm-
level innovation. Additionally, this effect is moderated by regional knowledge strength. 
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However, contrary to the hypotheses, the results do not reveal an interaction between 
the individual and organizational collaboration mechanism.    
 
The second question focused more on the quality of the innovation resulting from 
individual level collaborations. It is more related to evolutionary economics and the 
concepts of path dependency and local search. Prior research in this tradition has shown 
the firms search for knowledge locally i.e. in the neighborhood of their past practice and 
their current capabilities and expertise and its very difficult to change their  
technological trajectories (Nelson and Winter, 1982; Stuart and Podolny, 1996; 
Rosenkopf and Almeida, 2003; Benner and Tushman, 2003). However, in science and 
technology driven industries innovation is continuous, sometimes radical, and often 
rapid (Archibugi and Bizzarri, 2004) and, keeping close to the cutting edge of science 
and technology is difficult. The challenge for firms is not just to innovate but, when 
necessary, building innovative capabilities and expertise in new areas in order to keep 
close to the emerging frontier of innovation in the field.  I proposed that individual level 
collaboration of scientist might provide a tool to help firms to overcome this challenge. 
Because they can reach across organizational boundaries to collaborate with others on 
research activities and this can provide the organization with useful additional inputs for 
innovation. Additionally, these collaborations do not just lead to an increase in 
knowledge, but importantly facilitate insights and access to the knowledge from a wider 
spectrum than otherwise not available to the firm.  
 
The results support this arguments, firms with a greater number individual 
collaborations are more likely to move closer to the frontiers of innovation in 
biotechnology, while firms with greater number of strategic alliances and internal 
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individual collaborations are likely to move further away. I also find that technological 
specialization negatively affects the match with the future innovation frontiers and it 
reinforces the effect of strategic alliances and internal collaborations on future 
innovation.  
 
Besides the specific contributions discussed in the previous parts, I would like to 
highlight two overall contributions of this dissertation. Firstly, individual collaborations 
have a positive influence and innovation performance and enable firms to innovate in 
ways otherwise difficult to achieve. This suggests that individual collaboration provide 
an additional tool for managers at the individual- level, which helps in increase 
innovation performance. Thereby, it can not be assumed that individual collaboration 
are completely endogenous of the overall firm strategy, however, managers can 
intentionally integrate them in the strategy process. It might be difficult to organize and 
foresee individual collaboration top down, but top management can create structures 
and incentives to foster the ir creation.  
 
Secondly, the results build on a well established stream of research that examines the 
effect of collaboration at the organizational level. However, the dissertation moves 
beyond the emphasis of firm level collaborative mechanisms and highlights the 
importance of individual collaborations. Thus it shows the role of the underlying 
sociology of individuals in influencing observable organizational outcomes. In this way, 
it adds to the growing body of research that focuses on the implications of individual 
level phenomena such as mobility of engineers or hiring of star scientists in explaining 
organizational level outcomes. The research makes also the point that it can be fruitful  
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